Id |
Subject |
Object |
Predicate |
Lexical cue |
Negation |
Speculation |
T1896 |
14-19 |
Protein |
denotes |
IL-10 |
|
|
T1908 |
66-121 |
Gene_expression |
denotes |
expression of suppressor of cytokine signaling 1 in CD4 |
|
|
T1900 |
77-114 |
Protein |
denotes |
of suppressor of cytokine signaling 1 |
|
|
T1880 |
118-121 |
Protein |
denotes |
CD4 |
|
|
T1887 |
123-130 |
Entity |
denotes |
T cells |
|
|
T1870 |
181-186 |
Protein |
denotes |
IL-10 |
|
|
T1871 |
211-256 |
Protein |
denotes |
the antigen-specific T-cell cytokine response |
|
|
T1907 |
211-257 |
Localization |
denotes |
the antigen-specific T-cell cytokine response |
|
|
T1905 |
215-231 |
Entity |
denotes |
antigen-specific |
|
|
T1881 |
232-238 |
Entity |
denotes |
T-cell |
|
|
T1893 |
275-279 |
Protein |
denotes |
CD28 |
|
|
T1866 |
330-333 |
Protein |
denotes |
CD4 |
|
|
T1903 |
335-394 |
Entity |
denotes |
T cells from patients with active rheumatoid arthritis (RA) |
|
|
T1868 |
391-393 |
Protein |
denotes |
RA |
|
|
T1886 |
435-445 |
Protein |
denotes |
interferon |
|
|
T1891 |
458-461 |
Protein |
denotes |
CD3 |
|
|
T1885 |
466-470 |
Protein |
denotes |
CD28 |
|
|
T1906 |
466-484 |
Positive_regulation |
denotes |
CD28 costimulation |
|
|
T1859 |
504-517 |
Protein |
denotes |
1 ng/ml IL-10 |
|
|
T1875 |
543-546 |
Protein |
denotes |
CD4 |
|
|
T1889 |
548-555 |
Entity |
denotes |
T cells |
|
|
T1904 |
591-619 |
Protein |
denotes |
of the type 1 IL-10 receptor |
|
|
T1867 |
591-619 |
Protein |
denotes |
of the type 1 IL-10 receptor |
|
|
T1894 |
605-610 |
Protein |
denotes |
IL-10 |
|
|
T1910 |
635-708 |
Phosphorylation |
denotes |
The phosphorylation of signal transducer and activator of transcription 3 |
|
|
T1902 |
655-708 |
Protein |
denotes |
of signal transducer and activator of transcription 3 |
|
|
T1860 |
757-776 |
Entity |
denotes |
CD4+ T cells of RA, |
|
|
T1861 |
773-775 |
Protein |
denotes |
RA |
|
|
T1883 |
818-834 |
Protein |
denotes |
of 1 ng/ml IL-10 |
|
|
T1879 |
836-857 |
Protein |
denotes |
Sera from RA patients |
|
|
T1892 |
846-848 |
Protein |
denotes |
RA |
|
|
T1876 |
866-916 |
Protein |
denotes |
signal transducer and activator of transcription 3 |
|
|
T1914 |
866-955 |
Phosphorylation |
denotes |
signal transducer and activator of transcription 3 phosphorylation in normal CD4+ T cells |
|
|
T1877 |
936-955 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T1912 |
987-1018 |
Regulation |
denotes |
neutralizing anti-IL-6 antibody |
|
|
T1884 |
1000-1018 |
Protein |
denotes |
anti-IL-6 antibody |
|
|
T1901 |
1034-1047 |
Protein |
denotes |
of normal CD4 |
|
|
T1872 |
1049-1066 |
Entity |
denotes |
T cells with IL-6 |
|
|
T1918 |
1049-1131 |
Negative_regulation |
denotes |
T cells with IL-6 reduced IL-10-mediated inhibition of interferon gamma production |
|
|
T1874 |
1062-1066 |
Protein |
denotes |
IL-6 |
|
|
T1873 |
1075-1089 |
Protein |
denotes |
IL-10-mediated |
|
|
T1911 |
1075-1131 |
Regulation |
denotes |
IL-10-mediated inhibition of interferon gamma production |
|
|
T1898 |
1139-1151 |
Entity |
denotes |
CD4+ T cells |
|
|
T1869 |
1157-1159 |
Protein |
denotes |
RA |
|
|
T1890 |
1196-1230 |
Protein |
denotes |
suppressor of cytokine signaling 1 |
|
|
T1862 |
1251-1285 |
Protein |
denotes |
suppressor of cytokine signaling 3 |
|
|
T1899 |
1251-1325 |
Protein |
denotes |
suppressor of cytokine signaling 3 mRNA compared with control CD4+ T cells |
|
|
T1882 |
1300-1325 |
Entity |
denotes |
with control CD4+ T cells |
|
|
T1865 |
1341-1357 |
Protein |
denotes |
by real-time PCR |
|
|
T1888 |
1387-1389 |
Protein |
denotes |
RA |
|
|
T1863 |
1387-1402 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T1864 |
1452-1460 |
Protein |
denotes |
of IL-10 |
|
|
T1909 |
1504-1533 |
Positive_regulation |
denotes |
this impaired IL-10 signaling |
|
|
T1915 |
1504-1533 |
Negative_regulation |
denotes |
this impaired IL-10 signaling |
|
|
T1878 |
1518-1523 |
Protein |
denotes |
IL-10 |
|
|
T1913 |
1557-1628 |
Positive_regulation |
denotes |
sustained signal transducer and activator of transcription 3 activation |
|
|
T1897 |
1567-1617 |
Protein |
denotes |
signal transducer and activator of transcription 3 |
|
|
T1895 |
1633-1667 |
Protein |
denotes |
suppressor of cytokine signaling 1 |
|
|
T1916 |
1633-1677 |
Gene_expression |
denotes |
suppressor of cytokine signaling 1 induction |
|
|
T1917 |
1633-1677 |
Positive_regulation |
denotes |
suppressor of cytokine signaling 1 induction |
|
|
T6289 |
1693-1698 |
Protein |
denotes |
IL-10 |
|
|
T6225 |
1702-1716 |
Protein |
denotes |
a key cytokine |
|
|
T6186 |
1804-1832 |
Protein |
denotes |
of proinflammatory cytokines |
|
|
T6322 |
1834-1839 |
Protein |
denotes |
IL-10 |
|
|
T6346 |
1834-1884 |
Binding |
denotes |
IL-10 binds to the IL-10 receptor (IL-10R) complex |
|
|
T6274 |
1846-1884 |
Protein |
denotes |
to the IL-10 receptor (IL-10R) complex |
|
|
T6306 |
1846-1884 |
Entity |
denotes |
to the IL-10 receptor (IL-10R) complex |
|
|
T6297 |
1869-1875 |
Protein |
denotes |
IL-10R |
|
|
T6349 |
1919-1979 |
Binding |
denotes |
the primary ligand-binding component type 1 IL-10R (IL-10R1) |
|
|
T6167 |
1919-1979 |
Entity |
denotes |
the primary ligand-binding component type 1 IL-10R (IL-10R1) |
|
|
T6304 |
1946-1979 |
Protein |
denotes |
component type 1 IL-10R (IL-10R1) |
|
|
T6171 |
1971-1978 |
Protein |
denotes |
IL-10R1 |
|
|
T6178 |
1984-2021 |
Protein |
denotes |
the accessory component type 2 IL-10R |
|
|
T6354 |
2027-2062 |
Binding |
denotes |
The interaction of IL-10 and IL-10R |
|
|
T6215 |
2046-2051 |
Protein |
denotes |
IL-10 |
|
|
T6219 |
2056-2062 |
Protein |
denotes |
IL-10R |
|
|
T6246 |
2071-2122 |
Protein |
denotes |
the Janus kinase (JAK) family tyrosine kinases Jak1 |
|
|
T6169 |
2071-2122 |
Protein |
denotes |
the Janus kinase (JAK) family tyrosine kinases Jak1 |
|
|
T6198 |
2075-2080 |
Protein |
denotes |
Janus |
|
|
T6227 |
2081-2093 |
Protein |
denotes |
kinase (JAK) |
|
|
T6259 |
2089-2092 |
Protein |
denotes |
JAK |
|
|
T6230 |
2101-2109 |
Entity |
denotes |
tyrosine |
|
|
T6330 |
2127-2131 |
Protein |
denotes |
Tyk2 |
|
|
T6355 |
2133-2199 |
Binding |
denotes |
which are constitutively associated with IL-10R1 and type 2 IL-10R |
|
|
T6356 |
2133-2199 |
Binding |
denotes |
which are constitutively associated with IL-10R1 and type 2 IL-10R |
|
|
T6208 |
2174-2181 |
Protein |
denotes |
IL-10R1 |
|
|
T6234 |
2186-2199 |
Protein |
denotes |
type 2 IL-10R |
|
|
T6256 |
2219-2224 |
Protein |
denotes |
IL-10 |
|
|
T6263 |
2233-2257 |
Entity |
denotes |
tyrosine phosphorylation |
|
|
T6374 |
2262-2368 |
Positive_regulation |
denotes |
activation of the latent transcriptional factors signal transducer and activator of transcription (STAT) 3 |
|
|
T6216 |
2273-2368 |
Protein |
denotes |
of the latent transcriptional factors signal transducer and activator of transcription (STAT) 3 |
|
|
T6283 |
2373-2382 |
Protein |
denotes |
STAT1 [3] |
|
|
T6250 |
2406-2411 |
Protein |
denotes |
STAT1 |
|
|
T6345 |
2406-2533 |
Regulation |
denotes |
STAT1 and STAT3 proteins form homodimers or heterodimers, rapidly translocate into the nucleus, and modulate gene transcription |
|
|
T6344 |
2406-2533 |
Regulation |
denotes |
STAT1 and STAT3 proteins form homodimers or heterodimers, rapidly translocate into the nucleus, and modulate gene transcription |
|
|
T6272 |
2416-2421 |
Protein |
denotes |
STAT3 |
|
|
T6311 |
2416-2430 |
Protein |
denotes |
STAT3 proteins |
|
|
T6168 |
2436-2446 |
Entity |
denotes |
homodimers |
|
|
T6188 |
2450-2501 |
Entity |
denotes |
heterodimers, rapidly translocate into the nucleus, |
|
|
T6241 |
2489-2500 |
Entity |
denotes |
the nucleus |
|
|
T6199 |
2515-2519 |
Protein |
denotes |
gene |
|
|
T6347 |
2515-2533 |
Transcription |
denotes |
gene transcription |
|
|
T6190 |
2549-2554 |
Protein |
denotes |
STAT3 |
|
|
T6307 |
2581-2594 |
Protein |
denotes |
IL-10-derived |
|
|
T6313 |
2581-2612 |
Entity |
denotes |
IL-10-derived anti-inflammatory |
|
|
T6228 |
2617-2629 |
Protein |
denotes |
IL-6-derived |
|
|
T6295 |
2669-2696 |
Protein |
denotes |
of cell-type-specific STAT3 |
|
|
T6298 |
2707-2711 |
Protein |
denotes |
mice |
|
|
T6369 |
2717-2744 |
Positive_regulation |
denotes |
shown that STAT3 activation |
|
|
T6191 |
2728-2733 |
Protein |
denotes |
STAT3 |
|
|
T6282 |
2762-2776 |
Protein |
denotes |
IL-10-mediated |
|
|
T6317 |
2762-2840 |
Entity |
denotes |
IL-10-mediated anti-inflammatory reactions in macrophages and neutrophils [5], |
|
|
T6294 |
2808-2819 |
Entity |
denotes |
macrophages |
|
|
T6316 |
2824-2835 |
Entity |
denotes |
neutrophils |
|
|
T6372 |
2848-2901 |
Regulation |
denotes |
responsible for IL-6-mediated prevention of apoptosis |
|
|
T6267 |
2864-2877 |
Protein |
denotes |
IL-6-mediated |
|
|
T6336 |
2905-2916 |
Entity |
denotes |
T cells [6] |
|
|
T6275 |
2918-2961 |
Protein |
denotes |
The suppressor of cytokine signaling (SOCS) |
|
|
T6232 |
2956-2960 |
Protein |
denotes |
SOCS |
|
|
T6326 |
2962-2970 |
Protein |
denotes |
proteins |
|
|
T6224 |
3007-3039 |
Protein |
denotes |
endogenous JAK kinase inhibitors |
|
|
T6321 |
3007-3039 |
Entity |
denotes |
endogenous JAK kinase inhibitors |
|
|
T6310 |
3007-3039 |
Protein |
denotes |
endogenous JAK kinase inhibitors |
|
|
T6211 |
3018-3021 |
Protein |
denotes |
JAK |
|
|
T6231 |
3160-3187 |
Protein |
denotes |
cytokine signaling pathways |
|
|
T6213 |
3242-3247 |
Protein |
denotes |
SOCS3 |
|
|
T6286 |
3303-3308 |
Protein |
denotes |
IL-10 |
|
|
T6249 |
3313-3317 |
Protein |
denotes |
IL-6 |
|
|
T6341 |
3319-3406 |
Negative_regulation |
denotes |
by specifically blocking STAT3 activation induced by IL-6 but not that induced by IL-10 |
|
|
T6221 |
3344-3349 |
Protein |
denotes |
STAT3 |
|
|
T6353 |
3344-3406 |
Positive_regulation |
denotes |
STAT3 activation induced by IL-6 but not that induced by IL-10 |
|
|
T6279 |
3369-3376 |
Protein |
denotes |
by IL-6 |
|
|
T6176 |
3398-3406 |
Protein |
denotes |
by IL-10 |
|
|
T6164 |
3461-3463 |
Protein |
denotes |
RA |
|
|
T6212 |
3512-3533 |
Entity |
denotes |
of inflammatory cells |
|
|
T6287 |
3543-3554 |
Entity |
denotes |
lymphocytes |
|
|
T6315 |
3556-3567 |
Entity |
denotes |
macrophages |
|
|
T6237 |
3573-3588 |
Entity |
denotes |
dendritic cells |
|
|
T6182 |
3630-3651 |
Entity |
denotes |
fibroblast-like cells |
|
|
T6202 |
3630-3651 |
Entity |
denotes |
fibroblast-like cells |
|
|
T6296 |
3641-3651 |
Entity |
denotes |
like cells |
|
|
T6235 |
3653-3671 |
Protein |
denotes |
Numerous cytokines |
|
|
T6359 |
3653-3710 |
Gene_expression |
denotes |
Numerous cytokines are overproduced in the inflamed joint |
|
|
T6358 |
3653-3710 |
Positive_regulation |
denotes |
Numerous cytokines are overproduced in the inflamed joint |
|
|
T6327 |
3716-3727 |
Entity |
denotes |
macrophages |
|
|
T6175 |
3732-3752 |
Entity |
denotes |
synovial fibroblasts |
|
|
T6331 |
3777-3805 |
Protein |
denotes |
of proinflammatory cytokines |
|
|
T6194 |
3807-3842 |
Protein |
denotes |
Tumor necrosis factor alpha (TNF-α) |
|
|
T6273 |
3836-3841 |
Protein |
denotes |
TNF-α |
|
|
T6323 |
3847-3883 |
Protein |
denotes |
IL-1, two major macrophage products, |
|
|
T6293 |
3853-3882 |
Entity |
denotes |
two major macrophage products |
|
|
T6288 |
3863-3873 |
Entity |
denotes |
macrophage |
|
|
T6248 |
3980-3988 |
Entity |
denotes |
effector |
|
|
T6269 |
4011-4039 |
Protein |
denotes |
other inflammatory cytokines |
|
|
T6165 |
4041-4051 |
Protein |
denotes |
chemokines |
|
|
T6238 |
4069-4085 |
Protein |
denotes |
matrix proteases |
|
|
T6174 |
4087-4099 |
Entity |
denotes |
nitric oxide |
|
|
T6222 |
4135-4139 |
Protein |
denotes |
IL-6 |
|
|
T6196 |
4143-4213 |
Protein |
denotes |
a pleiotropic cytokine produced substantially by activated fibroblasts |
|
|
T6264 |
4192-4213 |
Entity |
denotes |
activated fibroblasts |
|
|
T6197 |
4315-4346 |
Entity |
denotes |
plasma cells, T-cell functions, |
|
|
T6177 |
4329-4335 |
Entity |
denotes |
T-cell |
|
|
T6220 |
4351-4379 |
Entity |
denotes |
hematopoietic precursor cell |
|
|
T6319 |
4411-4438 |
Entity |
denotes |
anti-inflammatory cytokines |
|
|
T6302 |
4411-4438 |
Protein |
denotes |
anti-inflammatory cytokines |
|
|
T6277 |
4443-4462 |
Protein |
denotes |
cytokine inhibitors |
|
|
T6262 |
4443-4462 |
Entity |
denotes |
cytokine inhibitors |
|
|
T6184 |
4503-4505 |
Protein |
denotes |
RA |
|
|
T6217 |
4514-4544 |
Protein |
denotes |
IL-10, produced by macrophages |
|
|
T6365 |
4514-4544 |
Gene_expression |
denotes |
IL-10, produced by macrophages |
|
|
T6335 |
4533-4544 |
Entity |
denotes |
macrophages |
|
|
T6271 |
4559-4595 |
Entity |
denotes |
T cells in the synovial tissue (ST), |
|
|
T6163 |
4591-4593 |
Protein |
denotes |
ST |
|
|
T6244 |
4638-4648 |
Entity |
denotes |
macrophage |
|
|
T6312 |
4653-4662 |
Entity |
denotes |
Th1 cells |
|
|
T6204 |
4780-4817 |
Entity |
denotes |
the anti-inflammatory action of IL-10 |
|
|
T6195 |
4809-4817 |
Protein |
denotes |
of IL-10 |
|
|
T6265 |
4907-4912 |
Protein |
denotes |
IL-10 |
|
|
T6342 |
4907-4922 |
Positive_regulation |
denotes |
IL-10 signaling |
|
|
T6368 |
4907-5023 |
Negative_regulation |
denotes |
IL-10 signaling is impaired in macrophages upon chronic exposure to proinflammatory cytokines such as TNF-α and IL-1 |
|
|
T6276 |
4938-4949 |
Entity |
denotes |
macrophages |
|
|
T6242 |
4975-5008 |
Protein |
denotes |
proinflammatory cytokines such as |
|
|
T6332 |
4975-5014 |
Protein |
denotes |
proinflammatory cytokines such as TNF-α |
|
|
T6303 |
5019-5023 |
Protein |
denotes |
IL-1 |
|
|
T6257 |
5028-5052 |
Entity |
denotes |
immune complexes [13,14] |
|
|
T6209 |
5054-5066 |
Entity |
denotes |
Cell surface |
|
|
T6351 |
5054-5088 |
Gene_expression |
denotes |
Cell surface expression of IL-10R1 |
|
|
T6189 |
5078-5088 |
Protein |
denotes |
of IL-10R1 |
|
|
T6308 |
5120-5229 |
Entity |
denotes |
dendritic cells due to the presence of TNF-α, IL-1, and granulocyte–macrophage colony-stimulating factor [15] |
|
|
T6337 |
5159-5164 |
Protein |
denotes |
TNF-α |
|
|
T6290 |
5166-5170 |
Protein |
denotes |
IL-1 |
|
|
T6281 |
5176-5198 |
Entity |
denotes |
granulocyte–macrophage |
|
|
T6260 |
5176-5198 |
Entity |
denotes |
granulocyte–macrophage |
|
|
T6179 |
5176-5229 |
Protein |
denotes |
granulocyte–macrophage colony-stimulating factor [15] |
|
|
T6373 |
5176-5229 |
Localization |
denotes |
granulocyte–macrophage colony-stimulating factor [15] |
|
|
T6192 |
5188-5198 |
Entity |
denotes |
macrophage |
|
|
T6268 |
5231-5243 |
Entity |
denotes |
CD4+ T cells |
|
|
T6210 |
5261-5287 |
Entity |
denotes |
by arthritogenic antigens, |
|
|
T6229 |
5308-5321 |
Protein |
denotes |
CD28-mediated |
|
|
T6350 |
5308-5352 |
Regulation |
denotes |
CD28-mediated costimulatory signaling, in RA |
|
|
T6166 |
5350-5352 |
Protein |
denotes |
RA |
|
|
T6187 |
5435-5474 |
Protein |
denotes |
the MHC class II antigens HLA-DRB1*0404 |
|
|
T6251 |
5435-5474 |
Protein |
denotes |
the MHC class II antigens HLA-DRB1*0404 |
|
|
T6205 |
5452-5460 |
Entity |
denotes |
antigens |
|
|
T6301 |
5479-5505 |
Protein |
denotes |
HLA-DRB1*0401 with disease |
|
|
T6320 |
5579-5591 |
Protein |
denotes |
MHC class II |
|
|
T6236 |
5579-5601 |
Entity |
denotes |
MHC class II molecules |
|
|
T6214 |
5606-5623 |
Entity |
denotes |
both CD28 ligands |
|
|
T6170 |
5611-5615 |
Protein |
denotes |
CD28 |
|
|
T6314 |
5625-5629 |
Protein |
denotes |
CD80 |
|
|
T6254 |
5634-5638 |
Protein |
denotes |
CD86 |
|
|
T6245 |
5643-5666 |
Protein |
denotes |
the inflamed ST [18-20] |
|
|
T6300 |
5696-5718 |
Entity |
denotes |
activated CD4+ T cells |
|
|
T6278 |
5794-5805 |
Entity |
denotes |
macrophages |
|
|
T6206 |
5810-5830 |
Entity |
denotes |
synovial fibroblasts |
|
|
T6185 |
5839-5851 |
Entity |
denotes |
cell surface |
|
|
T6338 |
5874-5886 |
Entity |
denotes |
cell surface |
|
|
T6180 |
5874-5891 |
Protein |
denotes |
cell surface CD69 |
|
|
T6371 |
5874-5892 |
Localization |
denotes |
cell surface CD69 |
|
|
T6218 |
5896-5900 |
Protein |
denotes |
CD11 |
|
|
T6247 |
5944-5965 |
Protein |
denotes |
Th1 cytokines such as |
|
|
T6243 |
5944-5976 |
Protein |
denotes |
Th1 cytokines such as interferon |
|
|
T6325 |
5984-5987 |
Protein |
denotes |
IFN |
|
|
T6291 |
5995-6000 |
Protein |
denotes |
IL-17 |
|
|
T6340 |
6010-6113 |
Positive_regulation |
denotes |
In addition, CD4+ T cells could stimulate B-cell production of autoantibodies such as rheumatoid factor |
|
true |
T6173 |
6023-6035 |
Entity |
denotes |
CD4+ T cells |
|
|
T6252 |
6052-6058 |
Entity |
denotes |
B-cell |
|
|
T6360 |
6052-6095 |
Gene_expression |
denotes |
B-cell production of autoantibodies such as |
|
|
T6233 |
6052-6113 |
Protein |
denotes |
B-cell production of autoantibodies such as rheumatoid factor |
|
|
T6200 |
6070-6087 |
Protein |
denotes |
of autoantibodies |
|
|
T6285 |
6118-6137 |
Entity |
denotes |
osteoclast-mediated |
|
|
T6370 |
6118-6154 |
Regulation |
denotes |
osteoclast-mediated bone destruction |
|
|
T6339 |
6181-6183 |
Protein |
denotes |
RA |
|
|
T6343 |
6259-6300 |
Negative_regulation |
denotes |
selective inhibition of T-cell activation |
|
|
T6172 |
6283-6289 |
Entity |
denotes |
T-cell |
|
|
T6193 |
6313-6374 |
Protein |
denotes |
protein of cytotoxic T-cell-associated antigen 4 (CD152)-IgG, |
|
|
T6239 |
6324-6374 |
Protein |
denotes |
cytotoxic T-cell-associated antigen 4 (CD152)-IgG, |
|
|
T6333 |
6409-6413 |
Protein |
denotes |
CD28 |
|
|
T6318 |
6417-6424 |
Entity |
denotes |
T cells |
|
|
T6352 |
6428-6475 |
Binding |
denotes |
binding to CD80 and CD86 with high avidity [23] |
|
|
T6292 |
6439-6443 |
Protein |
denotes |
CD80 |
|
|
T6183 |
6448-6452 |
Protein |
denotes |
CD86 |
|
|
T6258 |
6477-6482 |
Protein |
denotes |
IL-10 |
|
|
T6334 |
6502-6547 |
Protein |
denotes |
the antigen-specific T-cell cytokine response |
|
|
T6255 |
6506-6522 |
Entity |
denotes |
antigen-specific |
|
|
T6329 |
6523-6529 |
Entity |
denotes |
T-cell |
|
|
T6203 |
6566-6570 |
Protein |
denotes |
CD28 |
|
|
T6207 |
6648-6658 |
Entity |
denotes |
of antigen |
|
|
T6201 |
6670-6675 |
Entity |
denotes |
cells |
|
|
T6240 |
6705-6720 |
Entity |
denotes |
of CD4+ T cells |
|
|
T6305 |
6750-6752 |
Protein |
denotes |
RA |
|
|
T6357 |
6757-6793 |
Gene_expression |
denotes |
investigated the production of IFN-γ |
|
|
T6226 |
6785-6793 |
Protein |
denotes |
of IFN-γ |
|
|
T6270 |
6800-6803 |
Protein |
denotes |
CD3 |
|
|
T6299 |
6808-6812 |
Protein |
denotes |
CD28 |
|
|
T6348 |
6808-6826 |
Positive_regulation |
denotes |
CD28 costimulation |
|
|
T6253 |
6846-6851 |
Protein |
denotes |
IL-10 |
|
|
T6364 |
6853-6885 |
Gene_expression |
denotes |
the induction of STAT1 and STAT3 |
|
|
T6363 |
6853-6885 |
Positive_regulation |
denotes |
the induction of STAT1 and STAT3 |
|
|
T6362 |
6853-6885 |
Positive_regulation |
denotes |
the induction of STAT1 and STAT3 |
|
|
T6361 |
6853-6885 |
Gene_expression |
denotes |
the induction of STAT1 and STAT3 |
|
|
T6309 |
6870-6875 |
Protein |
denotes |
STAT1 |
|
|
T6284 |
6880-6885 |
Protein |
denotes |
STAT3 |
|
|
T6280 |
6902-6910 |
Protein |
denotes |
by IL-10 |
|
|
T6367 |
6916-6949 |
Gene_expression |
denotes |
the expression of SOCS1 and SOCS3 |
|
|
T6366 |
6916-6949 |
Gene_expression |
denotes |
the expression of SOCS1 and SOCS3 |
|
|
T6261 |
6934-6939 |
Protein |
denotes |
SOCS1 |
|
|
T6223 |
6944-6949 |
Protein |
denotes |
SOCS3 |
|
|
T6324 |
6976-6978 |
Protein |
denotes |
PB |
|
|
T6328 |
6980-6983 |
Protein |
denotes |
CD4 |
|
|
T6266 |
6985-6992 |
Entity |
denotes |
T cells |
|
|
T6181 |
6993-7000 |
Protein |
denotes |
from RA |
|
|
T7309 |
7115-7117 |
Protein |
denotes |
RA |
|
|
T7307 |
7364-7391 |
Entity |
denotes |
prednisolone (≤ 7.5 mg/day) |
|
|
T7310 |
7396-7433 |
Entity |
denotes |
disease-modifying antirheumatic drugs |
|
|
T7304 |
7522-7533 |
Entity |
denotes |
erythrocyte |
|
|
T7305 |
7581-7605 |
Protein |
denotes |
C-reactive protein (CRP) |
|
|
T7308 |
7601-7604 |
Protein |
denotes |
CRP |
|
|
T7306 |
7645-7662 |
Protein |
denotes |
rheumatoid factor |
|
|
T7303 |
7670-7681 |
Entity |
denotes |
142 ± 158 U |
|
|
T7311 |
7823-7826 |
Protein |
denotes |
CRP |
|
|
T7302 |
8084-8086 |
Protein |
denotes |
ST |
|
|
T7301 |
8120-8122 |
Protein |
denotes |
RA |
|
|
T7942 |
8214-8229 |
Entity |
denotes |
of CD4+ T cells |
|
|
T7947 |
8230-8271 |
Entity |
denotes |
Peripheral blood mononuclear cells (PBMC) |
|
|
T7933 |
8266-8270 |
Entity |
denotes |
PBMC |
|
|
T7934 |
8403-8415 |
Entity |
denotes |
CD4+ T cells |
|
|
T7929 |
8435-8461 |
Entity |
denotes |
PBMC by positive selection |
|
|
T7941 |
8504-8519 |
Protein |
denotes |
Miltenyi Biotec |
|
|
T7944 |
8587-8599 |
Entity |
denotes |
CD4+ T cells |
|
|
T7932 |
8619-8621 |
Protein |
denotes |
ST |
|
|
T7940 |
8676-8678 |
Protein |
denotes |
ST |
|
|
T7939 |
8721-8732 |
Protein |
denotes |
collagenase |
|
|
T7931 |
8737-8742 |
Protein |
denotes |
DNase |
|
|
T7936 |
8793-8812 |
Entity |
denotes |
ST cell suspensions |
|
|
T7943 |
8910-8940 |
Entity |
denotes |
25 mM HEPES (2 mM L-glutamine, |
|
|
T7938 |
8923-8939 |
Entity |
denotes |
2 mM L-glutamine |
|
|
T7946 |
8957-8969 |
Entity |
denotes |
amino acids, |
|
|
T7935 |
8980-8991 |
Entity |
denotes |
penicillin, |
|
|
T7930 |
9000-9018 |
Entity |
denotes |
mg/ml streptomycin |
|
|
T7945 |
9172-9190 |
Entity |
denotes |
Non-adherent cells |
|
|
T7948 |
9172-9205 |
Binding |
denotes |
Non-adherent cells were harvested |
|
|
T7937 |
9210-9222 |
Entity |
denotes |
CD4+ T cells |
|
|
T8565 |
9290-9305 |
Entity |
denotes |
of CD4+ T cells |
|
|
T8563 |
9306-9337 |
Protein |
denotes |
PB CD4+ T-cell populations were |
|
|
T8569 |
9314-9320 |
Entity |
denotes |
T-cell |
|
|
T8566 |
9419-9442 |
Entity |
denotes |
0.5 ml cell suspensions |
|
|
T8560 |
9419-9442 |
Entity |
denotes |
0.5 ml cell suspensions |
|
|
T8555 |
9518-9539 |
Protein |
denotes |
with 1 μg/ml anti-CD3 |
|
|
T8564 |
9577-9586 |
Entity |
denotes |
The cells |
|
|
T8557 |
9701-9709 |
Protein |
denotes |
of IL-10 |
|
|
T8571 |
9807-9827 |
Entity |
denotes |
Culture supernatants |
|
|
T8568 |
9862-9871 |
Entity |
denotes |
cell-free |
|
|
T8561 |
9907-9921 |
Protein |
denotes |
cytokine assay |
|
|
T8567 |
9945-9952 |
Protein |
denotes |
of IL-6 |
|
|
T8574 |
9956-9962 |
Entity |
denotes |
T-cell |
|
|
T8572 |
9978-9986 |
Protein |
denotes |
to IL-10 |
|
|
T8556 |
9988-10022 |
Entity |
denotes |
CD4+ T cells from healthy controls |
|
|
T8573 |
10088-10112 |
Protein |
denotes |
absence of 10 ng/ml IL-6 |
|
|
T8562 |
10146-10151 |
Entity |
denotes |
Cells |
|
|
T8558 |
10208-10217 |
Protein |
denotes |
anti-CD28 |
|
|
T8570 |
10249-10265 |
Protein |
denotes |
of 1 ng/ml IL-10 |
|
|
T8559 |
10306-10326 |
Protein |
denotes |
IFN-γ concentrations |
|
|
T8969 |
10358-10365 |
Protein |
denotes |
IL-10R1 |
|
|
T8978 |
10358-10376 |
Gene_expression |
denotes |
IL-10R1 expression |
|
|
T8976 |
10386-10410 |
Entity |
denotes |
of 5 × 105 cells of PBMC |
|
|
T8966 |
10406-10410 |
Entity |
denotes |
PBMC |
|
|
T8973 |
10447-10451 |
Entity |
denotes |
PBMC |
|
|
T8967 |
10519-10523 |
Protein |
denotes |
IgG1 |
|
|
T8974 |
10670-10694 |
Protein |
denotes |
IgG1 polyclonal antibody |
|
|
T8970 |
10670-10694 |
Protein |
denotes |
IgG1 polyclonal antibody |
|
|
T8975 |
10696-10735 |
Protein |
denotes |
Santa Cruz Biotechnologies, Santa Cruz, |
|
|
T8977 |
10746-10751 |
Entity |
denotes |
Cells |
|
|
T8968 |
10757-10810 |
Protein |
denotes |
then incubated with phycoerythrin-conjugated anti-CD4 |
|
|
T8971 |
10835-10840 |
Entity |
denotes |
Cells |
|
|
T8972 |
10863-10893 |
Entity |
denotes |
1% FCS/PBS between incubations |
|
|
T9275 |
10983-10988 |
Protein |
denotes |
IFN-γ |
|
|
T9279 |
10993-10997 |
Protein |
denotes |
IL-2 |
|
|
T9274 |
11016-11021 |
Protein |
denotes |
IFN-γ |
|
|
T9270 |
11026-11030 |
Protein |
denotes |
IL-2 |
|
|
T9280 |
11034-11070 |
Entity |
denotes |
culture supernatants of CD4+ T cells |
|
|
T9273 |
11058-11070 |
Entity |
denotes |
CD4+ T cells |
|
|
T9276 |
11139-11156 |
Protein |
denotes |
cytokine-specific |
|
|
T9278 |
11201-11230 |
Protein |
denotes |
recombinant cytokine proteins |
|
|
T9272 |
11201-11230 |
Protein |
denotes |
recombinant cytokine proteins |
|
|
T9271 |
11327-11332 |
Protein |
denotes |
IFN-γ |
|
|
T9277 |
11337-11341 |
Protein |
denotes |
IL-2 |
|
|
T10517 |
11371-11375 |
Protein |
denotes |
mRNA |
|
|
T10523 |
11380-11393 |
Protein |
denotes |
real-time PCR |
|
|
T10509 |
11432-11434 |
Protein |
denotes |
PB |
|
|
T10514 |
11432-11474 |
Entity |
denotes |
PB CD4+ T cells using an RNA isolation kit |
|
|
T10520 |
11457-11460 |
Protein |
denotes |
RNA |
|
|
T10529 |
11593-11602 |
Protein |
denotes |
total RNA |
|
|
T10510 |
11608-11658 |
Protein |
denotes |
Molony murine leukemia virus reverse transcriptase |
|
|
T10533 |
11706-11712 |
Entity |
denotes |
(dT)15 |
|
|
T10519 |
11750-11763 |
Protein |
denotes |
Real-time PCR |
|
|
T10531 |
11899-11902 |
Protein |
denotes |
Taq |
|
|
T10530 |
11899-11917 |
Protein |
denotes |
Taq DNA polymerase |
|
|
T10528 |
11922-11925 |
Entity |
denotes |
DNA |
|
|
T10511 |
11922-11961 |
Entity |
denotes |
DNA double-strand-specific SYBR Green I |
|
|
T10532 |
11979-11988 |
Entity |
denotes |
FastStart |
|
|
T10527 |
11989-12012 |
Entity |
denotes |
DNA Master SYBR Green I |
|
|
T10524 |
11989-12012 |
Entity |
denotes |
DNA Master SYBR Green I |
|
|
T10515 |
12234-12258 |
Protein |
denotes |
β-actin; at 95° C (10 s) |
|
|
T10534 |
12301-12306 |
Protein |
denotes |
SOCS1 |
|
|
T10526 |
12370-12375 |
Protein |
denotes |
SOCS3 |
|
|
T10516 |
12466-12473 |
Protein |
denotes |
melting |
|
|
T10518 |
12523-12528 |
Protein |
denotes |
SOCS1 |
|
|
T10525 |
12533-12538 |
Protein |
denotes |
SOCS3 |
|
|
T10522 |
12593-12600 |
Protein |
denotes |
β-actin |
|
|
T10535 |
12593-12611 |
Gene_expression |
denotes |
β-actin expression |
|
|
T10521 |
12666-12674 |
Protein |
denotes |
β-actin, |
|
|
T10513 |
12743-12749 |
Protein |
denotes |
SOCS1, |
|
|
T10512 |
12818-12824 |
Protein |
denotes |
SOCS3, |
|
|
T11878 |
12903-12915 |
Entity |
denotes |
CD4+ T cells |
|
|
T11855 |
12978-12983 |
Protein |
denotes |
IL-10 |
|
|
T11875 |
12988-12992 |
Protein |
denotes |
IL-6 |
|
|
T11836 |
13006-13022 |
Entity |
denotes |
of 5 × 105 cells |
|
|
T11888 |
13062-13122 |
Regulation |
denotes |
To examine the effect of serum IL-6 on STAT phosphorylation, |
|
|
T11866 |
13084-13097 |
Protein |
denotes |
of serum IL-6 |
|
|
T11889 |
13098-13121 |
Phosphorylation |
denotes |
on STAT phosphorylation |
|
|
T11838 |
13101-13105 |
Protein |
denotes |
STAT |
|
|
T11870 |
13123-13142 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T11834 |
13186-13188 |
Protein |
denotes |
RA |
|
|
T11837 |
13255-13274 |
Protein |
denotes |
polyclonal antibody |
|
|
T11827 |
13383-13388 |
Entity |
denotes |
cells |
|
|
T11853 |
13392-13402 |
Protein |
denotes |
100 μl SDS |
|
|
T11883 |
13403-13409 |
Protein |
denotes |
lysing |
|
|
T11844 |
13426-13434 |
Entity |
denotes |
Tris–HCl |
|
|
T11880 |
13426-13434 |
Entity |
denotes |
Tris–HCl |
|
|
T11832 |
13431-13434 |
Entity |
denotes |
HCl |
|
|
T11879 |
13436-13440 |
Entity |
denotes |
pH 6 |
|
|
T11839 |
13445-13510 |
Entity |
denotes |
2% SDS, 10% glycerol, 50 mM dithiothreitol, 0.1% bromphenol blue) |
|
|
T11847 |
13448-13466 |
Protein |
denotes |
SDS, 10% glycerol, |
|
|
T11830 |
13453-13465 |
Entity |
denotes |
10% glycerol |
|
|
T11869 |
13523-13538 |
Protein |
denotes |
protein samples |
|
|
T11846 |
13560-13587 |
Entity |
denotes |
10% SDS-polyacrylamide gels |
|
|
T11848 |
13564-13567 |
Protein |
denotes |
SDS |
|
|
T11841 |
13568-13582 |
Entity |
denotes |
polyacrylamide |
|
|
T11876 |
13612-13626 |
Entity |
denotes |
nitrocellulose |
|
|
T11862 |
13612-13668 |
Entity |
denotes |
nitrocellulose membranes (Amersham, Buckinghamshire, UK) |
|
|
T11833 |
13638-13667 |
Protein |
denotes |
Amersham, Buckinghamshire, UK |
|
|
T11877 |
13674-13686 |
Entity |
denotes |
the membrane |
|
|
T11873 |
13720-13733 |
Entity |
denotes |
Tris-buffered |
|
|
T11843 |
13720-13740 |
Entity |
denotes |
Tris-buffered saline |
|
|
T11887 |
13761-13769 |
Entity |
denotes |
Tyrosine |
|
|
T11891 |
13761-13877 |
Phosphorylation |
denotes |
Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits (Cell Signaling Technology, |
|
|
T11890 |
13761-13877 |
Phosphorylation |
denotes |
Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits (Cell Signaling Technology, |
|
|
T11874 |
13789-13794 |
Protein |
denotes |
STAT1 |
|
|
T11831 |
13799-13804 |
Protein |
denotes |
STAT3 |
|
|
T11885 |
13851-13855 |
Entity |
denotes |
Cell |
|
|
T11881 |
13951-13963 |
Entity |
denotes |
the membrane |
|
|
T11852 |
13983-14010 |
Entity |
denotes |
the antibodies (rabbit IgG) |
|
|
T11849 |
14011-14031 |
Entity |
denotes |
anti-STAT1 antibody, |
|
|
T11886 |
14011-14031 |
Protein |
denotes |
anti-STAT1 antibody, |
|
|
T11856 |
14032-14160 |
Entity |
denotes |
anti-phosphorylated tyrosine 701 of STAT1 antibody, anti-STAT3 antibody, and anti-phosphorylated tyrosine 705 of STAT3 antibody, |
|
|
T11884 |
14068-14073 |
Protein |
denotes |
STAT1 |
|
|
T11865 |
14068-14082 |
Entity |
denotes |
STAT1 antibody |
|
|
T11857 |
14084-14103 |
Protein |
denotes |
anti-STAT3 antibody |
|
|
T11829 |
14084-14103 |
Entity |
denotes |
anti-STAT3 antibody |
|
|
T11858 |
14109-14160 |
Entity |
denotes |
anti-phosphorylated tyrosine 705 of STAT3 antibody, |
|
|
T11867 |
14145-14150 |
Protein |
denotes |
STAT3 |
|
|
T11850 |
14145-14160 |
Protein |
denotes |
STAT3 antibody, |
|
|
T11854 |
14199-14212 |
Entity |
denotes |
Tris-buffered |
|
|
T11860 |
14199-14250 |
Entity |
denotes |
Tris-buffered saline with 0.1% Tween 20 with 5% BSA |
|
|
T11851 |
14225-14250 |
Entity |
denotes |
0.1% Tween 20 with 5% BSA |
|
|
T11861 |
14244-14250 |
Protein |
denotes |
5% BSA |
|
|
T11828 |
14252-14260 |
Protein |
denotes |
Antibody |
|
|
T11868 |
14285-14307 |
Protein |
denotes |
horseradish peroxidase |
|
|
T11872 |
14367-14380 |
Entity |
denotes |
Tris-buffered |
|
|
T11835 |
14367-14397 |
Entity |
denotes |
Tris-buffered saline with 0.1% |
|
|
T11842 |
14412-14419 |
Protein |
denotes |
5% BSA, |
|
|
T11882 |
14473-14518 |
Entity |
denotes |
Protein bands were quantified by densitometry |
|
|
T11845 |
14549-14553 |
Protein |
denotes |
STAT |
|
|
T11892 |
14549-14620 |
Phosphorylation |
denotes |
STAT phosphorylation was compared with the total amount of STAT protein |
|
|
T11864 |
14605-14620 |
Protein |
denotes |
of STAT protein |
|
|
T11863 |
14608-14612 |
Protein |
denotes |
STAT |
|
|
T11859 |
14622-14627 |
Protein |
denotes |
IFN-γ |
|
|
T11840 |
14628-14649 |
Entity |
denotes |
stimulated Hela cells |
|
|
T11871 |
14686-14691 |
Protein |
denotes |
STAT1 |
|
|
T12071 |
14801-14810 |
Entity |
denotes |
box plots |
|
|
T14335 |
15012-15017 |
Protein |
denotes |
IL-10 |
|
|
T14340 |
15012-15067 |
Negative_regulation |
denotes |
IL-10 inhibition of IFN-γ production in RA CD4+ T cells |
|
|
T14336 |
15029-15048 |
Gene_expression |
denotes |
of IFN-γ production |
|
|
T14326 |
15032-15037 |
Protein |
denotes |
IFN-γ |
|
|
T14321 |
15052-15054 |
Protein |
denotes |
RA |
|
|
T14327 |
15052-15067 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T14315 |
15068-15098 |
Protein |
denotes |
The CD28 costimulatory pathway |
|
|
T14271 |
15114-15140 |
Entity |
denotes |
effective antigen-specific |
|
|
T14318 |
15173-15178 |
Protein |
denotes |
IL-10 |
|
|
T14270 |
15229-15233 |
Protein |
denotes |
CD28 |
|
|
T14295 |
15229-15258 |
Entity |
denotes |
CD28 tyrosine phosphorylation |
|
|
T14319 |
15274-15303 |
Protein |
denotes |
phosphatidylinositol 3-kinase |
|
|
T14279 |
15341-15359 |
Entity |
denotes |
of RA CD4+ T cells |
|
|
T14301 |
15344-15346 |
Protein |
denotes |
RA |
|
|
T14290 |
15363-15369 |
Protein |
denotes |
IL-10, |
|
|
T14274 |
15379-15381 |
Protein |
denotes |
PB |
|
|
T14294 |
15379-15394 |
Entity |
denotes |
PB CD4+ T cells |
|
|
T14313 |
15420-15429 |
Protein |
denotes |
active RA |
|
|
T14277 |
15498-15501 |
Protein |
denotes |
CD3 |
|
|
T14291 |
15498-15510 |
Protein |
denotes |
CD3 antibody |
|
|
T14302 |
15515-15524 |
Protein |
denotes |
anti-CD28 |
|
|
T14322 |
15525-15533 |
Protein |
denotes |
antibody |
|
|
T14316 |
15573-15595 |
Protein |
denotes |
of IL-10 for 36 hours, |
|
|
T14304 |
15600-15605 |
Protein |
denotes |
IFN-γ |
|
|
T14350 |
15600-15616 |
Gene_expression |
denotes |
IFN-γ production |
|
|
T14276 |
15652-15655 |
Protein |
denotes |
Fig |
|
|
T14324 |
15660-15665 |
Protein |
denotes |
IFN-γ |
|
|
T14348 |
15660-15709 |
Gene_expression |
denotes |
IFN-γ production by activated normal CD4+ T cells |
|
|
T14314 |
15677-15709 |
Entity |
denotes |
by activated normal CD4+ T cells |
|
|
T14312 |
15714-15772 |
Protein |
denotes |
mostly inhibited at concentrations as low as 1 ng/ml IL-10 |
|
|
T14334 |
15783-15785 |
Protein |
denotes |
RA |
|
|
T14333 |
15783-15798 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T14305 |
15840-15848 |
Protein |
denotes |
of IFN-γ |
|
|
T14298 |
15868-15881 |
Protein |
denotes |
1 ng/ml IL-10 |
|
|
T14342 |
15887-15948 |
Binding |
denotes |
the maximal but not complete inhibition by IL-10 was obtained |
|
|
T14306 |
15927-15935 |
Protein |
denotes |
by IL-10 |
|
|
T14286 |
15997-16002 |
Protein |
denotes |
IFN-γ |
|
|
T14341 |
15997-16029 |
Gene_expression |
denotes |
IFN-γ production by CD4+ T cells |
|
|
T14285 |
16014-16029 |
Entity |
denotes |
by CD4+ T cells |
|
|
T14283 |
16036-16039 |
Protein |
denotes |
CD3 |
|
|
T14297 |
16044-16048 |
Protein |
denotes |
CD28 |
|
|
T14339 |
16044-16062 |
Positive_regulation |
denotes |
CD28 costimulation |
|
|
T14329 |
16082-16110 |
Protein |
denotes |
1 ng/ml IL-10 in RA patients |
|
|
T14309 |
16099-16101 |
Protein |
denotes |
RA |
|
|
T14299 |
16162-16165 |
Protein |
denotes |
CRP |
|
|
T14323 |
16219-16222 |
Protein |
denotes |
CRP |
|
|
T14320 |
16325-16330 |
Protein |
denotes |
IFN-γ |
|
|
T14346 |
16325-16380 |
Gene_expression |
denotes |
IFN-γ production without IL-10 among these three groups |
|
|
T14325 |
16350-16355 |
Protein |
denotes |
IL-10 |
|
|
T14293 |
16382-16385 |
Protein |
denotes |
Fig |
|
|
T14349 |
16411-16446 |
Regulation |
denotes |
effect of IL-10 on IFN-γ production |
|
|
T14337 |
16411-16495 |
Negative_regulation |
denotes |
effect of IL-10 on IFN-γ production was significantly limited in the active RA group |
|
|
T14296 |
16418-16426 |
Protein |
denotes |
of IL-10 |
|
|
T14338 |
16427-16446 |
Gene_expression |
denotes |
on IFN-γ production |
|
|
T14269 |
16430-16435 |
Protein |
denotes |
IFN-γ |
|
|
T14328 |
16487-16489 |
Protein |
denotes |
RA |
|
|
T14288 |
16526-16528 |
Protein |
denotes |
RA |
|
|
T14272 |
16578-16587 |
Protein |
denotes |
active RA |
|
|
T14273 |
16602-16613 |
Protein |
denotes |
inactive RA |
|
|
T14278 |
16653-16656 |
Protein |
denotes |
Fig |
|
|
T14287 |
16681-16717 |
Entity |
denotes |
CD4+ T cells from active RA patients |
|
|
T14332 |
16706-16708 |
Protein |
denotes |
RA |
|
|
T14281 |
16744-16749 |
Protein |
denotes |
IFN-γ |
|
|
T14308 |
16769-16782 |
Protein |
denotes |
1 ng/ml IL-10 |
|
|
T14330 |
16792-16811 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T14344 |
16823-16912 |
Gene_expression |
denotes |
In addition, we compared IL-2 production by CD4+ T cells after CD3 and CD28 costimulation |
|
|
T14303 |
16848-16852 |
Protein |
denotes |
IL-2 |
|
|
T14310 |
16864-16912 |
Entity |
denotes |
by CD4+ T cells after CD3 and CD28 costimulation |
|
|
T14275 |
16886-16889 |
Protein |
denotes |
CD3 |
|
|
T14280 |
16894-16898 |
Protein |
denotes |
CD28 |
|
|
T14343 |
16894-16912 |
Positive_regulation |
denotes |
CD28 costimulation |
|
|
T14300 |
16932-16983 |
Protein |
denotes |
IL-10 in active RA patients and in healthy controls |
|
|
T14289 |
16948-16950 |
Protein |
denotes |
RA |
|
|
T14307 |
16996-17000 |
Protein |
denotes |
IL-2 |
|
|
T14345 |
16996-17011 |
Gene_expression |
denotes |
IL-2 production |
|
|
T14347 |
16996-17082 |
Regulation |
denotes |
IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease, |
true |
|
T14331 |
17029-17045 |
Protein |
denotes |
by 1 ng/ml IL-10 |
|
|
T14317 |
17049-17051 |
Protein |
denotes |
RA |
|
|
T14311 |
17154-17171 |
Entity |
denotes |
61.1 ± 13.7%; P < |
|
|
T14282 |
17223-17225 |
Protein |
denotes |
RA |
|
|
T14284 |
17223-17238 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T14292 |
17294-17302 |
Protein |
denotes |
of IL-10 |
|
|
T15283 |
17350-17392 |
Localization |
denotes |
of cell surface IL-10R1 on RA CD4+ T cells |
|
|
T15257 |
17350-17392 |
Protein |
denotes |
of cell surface IL-10R1 on RA CD4+ T cells |
|
|
T15256 |
17350-17392 |
Entity |
denotes |
of cell surface IL-10R1 on RA CD4+ T cells |
|
|
T15259 |
17353-17365 |
Entity |
denotes |
cell surface |
|
|
T15263 |
17377-17379 |
Protein |
denotes |
RA |
|
|
T15278 |
17393-17433 |
Entity |
denotes |
The functional receptor complex of IL-10 |
|
|
T15262 |
17393-17433 |
Protein |
denotes |
The functional receptor complex of IL-10 |
|
|
T15264 |
17425-17433 |
Protein |
denotes |
of IL-10 |
|
|
T15277 |
17460-17502 |
Protein |
denotes |
the primary ligand-binding component IL-10 |
|
|
T15273 |
17460-17502 |
Entity |
denotes |
the primary ligand-binding component IL-10 |
|
|
T15269 |
17502-17504 |
Protein |
denotes |
R1 |
|
|
T15275 |
17538-17550 |
Protein |
denotes |
2 IL-10R [1] |
|
|
T15276 |
17552-17559 |
Protein |
denotes |
IL-10R1 |
|
|
T15286 |
17552-17570 |
Gene_expression |
denotes |
IL-10R1 expression |
|
|
T15271 |
17618-17628 |
Protein |
denotes |
IL-10 [29] |
|
|
T15272 |
17667-17672 |
Protein |
denotes |
IL-10 |
|
|
T15285 |
17667-17683 |
Negative_regulation |
denotes |
IL-10 inhibition |
|
|
T15279 |
17687-17689 |
Protein |
denotes |
RA |
|
|
T15261 |
17687-17702 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T15288 |
17714-17742 |
Negative_regulation |
denotes |
limited receptor expression, |
|
|
T15287 |
17714-17742 |
Gene_expression |
denotes |
limited receptor expression, |
|
|
T15274 |
17722-17730 |
Protein |
denotes |
receptor |
|
|
T15266 |
17743-17759 |
Entity |
denotes |
the cell surface |
|
|
T15282 |
17774-17781 |
Protein |
denotes |
IL-10R1 |
|
|
T15255 |
17774-17800 |
Entity |
denotes |
IL-10R1 on PB CD4+ T cells |
|
|
T15265 |
17785-17787 |
Protein |
denotes |
PB |
|
|
T15267 |
17813-17815 |
Protein |
denotes |
RA |
|
|
T15270 |
17907-17910 |
Protein |
denotes |
Fig |
|
|
T15284 |
17933-17954 |
Gene_expression |
denotes |
of IL-10R1 expression |
|
|
T15268 |
17936-17943 |
Protein |
denotes |
IL-10R1 |
|
|
T15281 |
17958-17970 |
Entity |
denotes |
CD4+ T cells |
|
|
T15258 |
18002-18004 |
Protein |
denotes |
RA |
|
|
T15280 |
18125-18130 |
Protein |
denotes |
IL-10 |
|
|
T15260 |
18150-18175 |
Entity |
denotes |
CD4+ T cells of active RA |
|
|
T15254 |
18166-18175 |
Protein |
denotes |
active RA |
|
|
T16949 |
18178-18193 |
Protein |
denotes |
Defective IL-10 |
|
|
T17010 |
18178-18243 |
Regulation |
denotes |
Defective IL-10-mediated STAT3 phosphorylation in RA CD4+ T cells |
|
|
T16968 |
18203-18208 |
Protein |
denotes |
STAT3 |
|
|
T17007 |
18203-18243 |
Phosphorylation |
denotes |
STAT3 phosphorylation in RA CD4+ T cells |
|
|
T16969 |
18228-18230 |
Protein |
denotes |
RA |
|
|
T16976 |
18228-18243 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T17006 |
18244-18280 |
Binding |
denotes |
The interaction of IL-10R with IL-10 |
|
|
T16960 |
18260-18269 |
Protein |
denotes |
of IL-10R |
|
|
T16981 |
18270-18280 |
Protein |
denotes |
with IL-10 |
|
|
T16999 |
18289-18297 |
Entity |
denotes |
tyrosine |
|
|
T17018 |
18318-18370 |
Positive_regulation |
denotes |
activation of the latent transcription factors STAT1 |
|
|
T16948 |
18329-18370 |
Protein |
denotes |
of the latent transcription factors STAT1 |
|
|
T16983 |
18329-18370 |
Protein |
denotes |
of the latent transcription factors STAT1 |
|
|
T16950 |
18375-18384 |
Protein |
denotes |
STAT3 [3] |
|
|
T16984 |
18386-18405 |
Entity |
denotes |
Macrophage-specific |
|
|
T16986 |
18386-18426 |
Protein |
denotes |
Macrophage-specific STAT3-deficient mice |
|
|
T16959 |
18445-18450 |
Protein |
denotes |
STAT3 |
|
|
T16997 |
18476-18490 |
Protein |
denotes |
IL-10-mediated |
|
|
T16951 |
18561-18578 |
Entity |
denotes |
human macrophages |
|
|
T17017 |
18590-18636 |
Positive_regulation |
denotes |
of dominant-negative STAT3 overexpression [30] |
|
|
T17016 |
18590-18636 |
Gene_expression |
denotes |
of dominant-negative STAT3 overexpression [30] |
|
|
T16980 |
18590-18636 |
Protein |
denotes |
of dominant-negative STAT3 overexpression [30] |
|
|
T16963 |
18602-18616 |
Protein |
denotes |
negative STAT3 |
|
|
T16977 |
18655-18660 |
Protein |
denotes |
STAT1 |
|
|
T16982 |
18665-18670 |
Protein |
denotes |
STAT3 |
|
|
T17005 |
18665-18686 |
Phosphorylation |
denotes |
STAT3 phosphorylation |
|
|
T16952 |
18687-18705 |
Protein |
denotes |
by IL-10 in PB CD4 |
|
|
T16993 |
18699-18701 |
Protein |
denotes |
PB |
|
|
T16970 |
18699-18705 |
Protein |
denotes |
PB CD4 |
|
|
T16994 |
18707-18738 |
Entity |
denotes |
T cells from active RA patients |
|
|
T16973 |
18727-18729 |
Protein |
denotes |
RA |
|
|
T16985 |
18802-18807 |
Protein |
denotes |
STAT3 |
|
|
T17002 |
18802-18823 |
Phosphorylation |
denotes |
STAT3 phosphorylation |
|
|
T16987 |
18859-18864 |
Protein |
denotes |
IL-10 |
|
|
T17013 |
18859-18882 |
Positive_regulation |
denotes |
IL-10 activation for 20 |
|
|
T16967 |
18890-18909 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T17001 |
18911-18914 |
Protein |
denotes |
Fig |
|
|
T17008 |
18924-18995 |
Phosphorylation |
denotes |
In contrast, STAT3 was phosphorylated in freshly isolated PB CD4+ cells |
|
|
T16971 |
18937-18942 |
Protein |
denotes |
STAT3 |
|
|
T16998 |
18965-18995 |
Entity |
denotes |
freshly isolated PB CD4+ cells |
|
|
T17000 |
18982-18984 |
Protein |
denotes |
PB |
|
|
T16964 |
19001-19003 |
Protein |
denotes |
RA |
|
|
T17014 |
19017-19043 |
Phosphorylation |
denotes |
this STAT3 phosphorylation |
|
|
T16957 |
19022-19027 |
Protein |
denotes |
STAT3 |
|
|
T16991 |
19078-19083 |
Protein |
denotes |
STAT3 |
|
|
T17004 |
19078-19099 |
Phosphorylation |
denotes |
STAT3 phosphorylation |
|
|
T16955 |
19104-19162 |
Protein |
denotes |
augmented only when activated by as much as 10 ng/ml IL-10 |
|
|
T16990 |
19179-19184 |
Protein |
denotes |
STAT3 |
|
|
T17020 |
19179-19200 |
Phosphorylation |
denotes |
STAT3 phosphorylation |
|
|
T16995 |
19205-19228 |
Protein |
denotes |
defective IL-10-induced |
|
|
T17003 |
19205-19250 |
Phosphorylation |
denotes |
defective IL-10-induced STAT3 phosphorylation |
|
|
T16965 |
19229-19234 |
Protein |
denotes |
STAT3 |
|
|
T16975 |
19265-19267 |
Protein |
denotes |
RA |
|
|
T16954 |
19265-19283 |
Entity |
denotes |
RA ST CD4+ T cells |
|
|
T16953 |
19265-19283 |
Protein |
denotes |
RA ST CD4+ T cells |
|
|
T16962 |
19285-19288 |
Protein |
denotes |
Fig |
|
|
T17009 |
19295-19415 |
Phosphorylation |
denotes |
On the other hand, IL-10-induced STAT1 phosphorylation was not detected in either RA CD4+ T cells or normal CD4+ T cells |
|
|
T16972 |
19314-19327 |
Protein |
denotes |
IL-10-induced |
|
|
T16996 |
19328-19333 |
Protein |
denotes |
STAT1 |
|
|
T16946 |
19377-19379 |
Protein |
denotes |
RA |
|
|
T16974 |
19377-19392 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T16961 |
19396-19415 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T16979 |
19417-19420 |
Protein |
denotes |
Fig |
|
|
T16992 |
19455-19460 |
Protein |
denotes |
STAT3 |
|
|
T17012 |
19464-19510 |
Positive_regulation |
denotes |
the major IL-10-activated STAT in CD4+ T cells |
|
|
T16947 |
19464-19510 |
Protein |
denotes |
the major IL-10-activated STAT in CD4+ T cells |
|
|
T17019 |
19464-19510 |
Localization |
denotes |
the major IL-10-activated STAT in CD4+ T cells |
|
|
T16978 |
19468-19489 |
Protein |
denotes |
major IL-10-activated |
|
|
T16958 |
19498-19510 |
Entity |
denotes |
CD4+ T cells |
|
|
T16966 |
19516-19529 |
Protein |
denotes |
IL-10-induced |
|
|
T17015 |
19516-19546 |
Positive_regulation |
denotes |
IL-10-induced STAT3 activation |
|
|
T16989 |
19530-19535 |
Protein |
denotes |
STAT3 |
|
|
T16956 |
19568-19578 |
Protein |
denotes |
active RA, |
|
|
T17011 |
19594-19630 |
Phosphorylation |
denotes |
with sustained STAT3 phosphorylation |
|
|
T16988 |
19609-19614 |
Protein |
denotes |
STAT3 |
|
|
T19733 |
19633-19637 |
Protein |
denotes |
IL-6 |
|
|
T19727 |
19647-19652 |
Protein |
denotes |
STAT3 |
|
|
T19800 |
19647-19668 |
Phosphorylation |
denotes |
STAT3 phosphorylation |
|
|
T19788 |
19673-19713 |
Negative_regulation |
denotes |
inhibition of IL-10 effect in normal CD4 |
|
|
T19718 |
19687-19692 |
Protein |
denotes |
IL-10 |
|
|
T19743 |
19703-19713 |
Protein |
denotes |
normal CD4 |
|
|
T19736 |
19715-19722 |
Entity |
denotes |
T cells |
|
|
T19706 |
19723-19728 |
Protein |
denotes |
STAT3 |
|
|
T19794 |
19723-19741 |
Positive_regulation |
denotes |
STAT3 is activated |
|
|
T19755 |
19791-19795 |
Protein |
denotes |
IL-6 |
|
|
T19776 |
19806-19875 |
Protein |
denotes |
cytokines (IL-6, IL-11, leukemia inhibitory factor, and oncostatin M) |
|
|
T19716 |
19817-19821 |
Protein |
denotes |
IL-6 |
|
|
T19760 |
19823-19828 |
Protein |
denotes |
IL-11 |
|
|
T19768 |
19830-19856 |
Protein |
denotes |
leukemia inhibitory factor |
|
|
T19707 |
19862-19874 |
Protein |
denotes |
oncostatin M |
|
|
T19762 |
19877-19907 |
Protein |
denotes |
platelet-derived growth factor |
|
|
T19721 |
19913-19936 |
Protein |
denotes |
epidermal growth factor |
|
|
T19780 |
19953-19963 |
Protein |
denotes |
IL-10 [4], |
|
|
T19779 |
20008-20012 |
Protein |
denotes |
IL-6 |
|
|
T19710 |
20036-20038 |
Protein |
denotes |
RA |
|
|
T19796 |
20067-20125 |
Positive_regulation |
denotes |
constitutive activation of STAT3 in mononuclear cells [31] |
|
|
T19764 |
20091-20099 |
Protein |
denotes |
of STAT3 |
|
|
T19744 |
20103-20125 |
Entity |
denotes |
mononuclear cells [31] |
|
|
T19709 |
20133-20137 |
Protein |
denotes |
IL-6 |
|
|
T19703 |
20158-20185 |
Protein |
denotes |
sera of active RA patients, |
|
|
T19731 |
20173-20175 |
Protein |
denotes |
RA |
|
|
T19766 |
20265-20280 |
Entity |
denotes |
of CD4+ T cells |
|
|
T19726 |
20304-20311 |
Protein |
denotes |
of IL-6 |
|
|
T19741 |
20373-20378 |
Protein |
denotes |
STAT3 |
|
|
T19717 |
20408-20413 |
Protein |
denotes |
IL-10 |
|
|
T19801 |
20408-20437 |
Negative_regulation |
denotes |
IL-10 inhibition in active RA |
|
|
T19752 |
20428-20437 |
Protein |
denotes |
active RA |
|
|
T19750 |
20444-20449 |
Protein |
denotes |
STAT1 |
|
|
T19730 |
20454-20459 |
Protein |
denotes |
STAT3 |
|
|
T19705 |
20490-20497 |
Protein |
denotes |
by IL-6 |
|
|
T19711 |
20501-20537 |
Entity |
denotes |
normal CD4+ T cells (data not shown) |
|
|
T19778 |
20584-20594 |
Protein |
denotes |
Normal CD4 |
|
|
T19745 |
20596-20603 |
Entity |
denotes |
T cells |
|
|
T19758 |
20688-20690 |
Protein |
denotes |
RA |
|
|
T19729 |
20717-20755 |
Entity |
denotes |
anti-IL-6 antibody or control antibody |
|
|
T19777 |
20727-20735 |
Entity |
denotes |
antibody |
|
|
T19771 |
20761-20765 |
Protein |
denotes |
STAT |
|
|
T19797 |
20761-20819 |
Phosphorylation |
denotes |
STAT phosphorylation was examined by western blot analysis |
|
|
T19747 |
20821-20823 |
Protein |
denotes |
RA |
|
|
T19754 |
20849-20857 |
Entity |
denotes |
tyrosine |
|
|
T19795 |
20849-20896 |
Phosphorylation |
denotes |
tyrosine phosphorylation of STAT3 but not STAT1 |
|
|
T19712 |
20874-20882 |
Protein |
denotes |
of STAT3 |
|
|
T19742 |
20891-20896 |
Protein |
denotes |
STAT1 |
|
|
T19789 |
20902-20923 |
Positive_regulation |
denotes |
this STAT3 activation |
|
|
T19756 |
20907-20912 |
Protein |
denotes |
STAT3 |
|
|
T19738 |
20966-20970 |
Protein |
denotes |
IL-6 |
|
|
T19732 |
20981-20984 |
Protein |
denotes |
Fig |
|
|
T19763 |
21019-21023 |
Protein |
denotes |
IL-6 |
|
|
T19781 |
21077-21103 |
Protein |
denotes |
sera of active RA patients |
|
|
T19751 |
21092-21094 |
Protein |
denotes |
RA |
|
|
T19787 |
21114-21133 |
Positive_regulation |
denotes |
of STAT1 activation |
|
|
T19737 |
21117-21122 |
Protein |
denotes |
STAT1 |
|
|
T19753 |
21134-21139 |
Protein |
denotes |
by RA |
|
|
T19769 |
21187-21194 |
Protein |
denotes |
of IL-6 |
|
|
T19715 |
21215-21220 |
Protein |
denotes |
STAT1 |
|
|
T19783 |
21215-21231 |
Positive_regulation |
denotes |
STAT1 activation |
|
|
T19798 |
21244-21265 |
Positive_regulation |
denotes |
with STAT3 activation |
|
|
T19740 |
21249-21254 |
Protein |
denotes |
STAT3 |
|
|
T19713 |
21270-21304 |
Entity |
denotes |
that inhibitors of STAT1 signaling |
|
|
T19720 |
21289-21294 |
Protein |
denotes |
STAT1 |
|
|
T19793 |
21289-21304 |
Positive_regulation |
denotes |
STAT1 signaling |
|
|
T19761 |
21323-21325 |
Entity |
denotes |
RA |
|
|
T19773 |
21358-21362 |
Protein |
denotes |
IL-6 |
|
|
T19791 |
21358-21432 |
Negative_regulation |
denotes |
IL-6 could suppress the effect of IL-10 to inhibit IFN-γ production by CD4 |
|
true |
T19767 |
21389-21397 |
Protein |
denotes |
of IL-10 |
|
|
T19799 |
21401-21432 |
Negative_regulation |
denotes |
inhibit IFN-γ production by CD4 |
|
|
T19746 |
21409-21414 |
Protein |
denotes |
IFN-γ |
|
|
T19786 |
21409-21432 |
Gene_expression |
denotes |
IFN-γ production by CD4 |
|
|
T19704 |
21426-21432 |
Protein |
denotes |
by CD4 |
|
|
T19757 |
21434-21441 |
Entity |
denotes |
T cells |
|
|
T19722 |
21479-21506 |
Protein |
denotes |
10 ng/ml IL-6 for 36 hours, |
|
|
T19708 |
21507-21526 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T19714 |
21546-21549 |
Protein |
denotes |
CD3 |
|
|
T19765 |
21554-21558 |
Protein |
denotes |
CD28 |
|
|
T19785 |
21554-21572 |
Positive_regulation |
denotes |
CD28 costimulation |
|
|
T19772 |
21600-21630 |
Protein |
denotes |
of 1 ng/ml IL-10 for 36 hours, |
|
|
T19784 |
21635-21655 |
Gene_expression |
denotes |
the IFN-γ production |
|
|
T19724 |
21639-21644 |
Protein |
denotes |
IFN-γ |
|
|
T19735 |
21679-21683 |
Protein |
denotes |
IL-6 |
|
|
T19734 |
21700-21712 |
Entity |
denotes |
normal cells |
|
|
T19725 |
21721-21735 |
Protein |
denotes |
IL-10-mediated |
|
|
T19782 |
21721-21746 |
Regulation |
denotes |
IL-10-mediated inhibition |
|
|
T19728 |
21750-21755 |
Protein |
denotes |
IFN-γ |
|
|
T19790 |
21750-21766 |
Gene_expression |
denotes |
IFN-γ production |
|
|
T19739 |
21768-21771 |
Protein |
denotes |
Fig |
|
|
T19774 |
21814-21821 |
Protein |
denotes |
of IL-6 |
|
|
T19748 |
21837-21843 |
Entity |
denotes |
T-cell |
|
|
T19775 |
21859-21867 |
Protein |
denotes |
to IL-10 |
|
|
T19770 |
21942-21946 |
Protein |
denotes |
IL-6 |
|
|
T19792 |
21985-22004 |
Positive_regulation |
denotes |
of STAT3 activation |
|
|
T19723 |
21988-21993 |
Protein |
denotes |
STAT3 |
|
|
T19719 |
22049-22057 |
Protein |
denotes |
of IL-10 |
|
|
T19749 |
22061-22063 |
Protein |
denotes |
RA |
|
|
T19759 |
22061-22076 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T21417 |
22079-22127 |
Gene_expression |
denotes |
High expression of SOCS1 mRNA in RA CD4+ T cells |
|
|
T21362 |
22095-22108 |
Protein |
denotes |
of SOCS1 mRNA |
|
|
T21398 |
22098-22103 |
Protein |
denotes |
SOCS1 |
|
|
T21410 |
22112-22114 |
Protein |
denotes |
RA |
|
|
T21385 |
22112-22127 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T21376 |
22128-22132 |
Protein |
denotes |
IL-6 |
|
|
T21388 |
22141-22197 |
Entity |
denotes |
two potent inhibitors of JAKs (SOCS1 and SOCS3 proteins) |
|
|
T21379 |
22166-22197 |
Protein |
denotes |
JAKs (SOCS1 and SOCS3 proteins) |
|
|
T21382 |
22172-22177 |
Protein |
denotes |
SOCS1 |
|
|
T21364 |
22182-22187 |
Protein |
denotes |
SOCS3 |
|
|
T21407 |
22182-22196 |
Protein |
denotes |
SOCS3 proteins |
|
|
T21396 |
22325-22362 |
Protein |
denotes |
other cytokine-signaling pathways [7] |
|
|
T21375 |
22364-22369 |
Protein |
denotes |
SOCS3 |
|
|
T21401 |
22418-22423 |
Protein |
denotes |
STAT3 |
|
|
T21419 |
22418-22467 |
Positive_regulation |
denotes |
STAT3 activation induced by IL-6 but not by IL-10 |
|
|
T21405 |
22443-22450 |
Protein |
denotes |
by IL-6 |
|
|
T21380 |
22462-22467 |
Protein |
denotes |
IL-10 |
|
|
T21391 |
22512-22516 |
Protein |
denotes |
IL-6 |
|
|
T21361 |
22521-22526 |
Protein |
denotes |
IL-10 |
|
|
T21366 |
22551-22556 |
Protein |
denotes |
SOCS1 |
|
|
T21404 |
22586-22600 |
Protein |
denotes |
IL-10-mediated |
|
|
T21424 |
22586-22617 |
Regulation |
denotes |
IL-10-mediated STAT3 activation |
|
|
T21423 |
22586-22617 |
Positive_regulation |
denotes |
IL-10-mediated STAT3 activation |
|
|
T21400 |
22601-22606 |
Protein |
denotes |
STAT3 |
|
|
T21386 |
22653-22667 |
Protein |
denotes |
IFN-γ-mediated |
|
|
T21416 |
22653-22689 |
Positive_regulation |
denotes |
IFN-γ-mediated STAT1 activation [32] |
|
|
T21415 |
22653-22689 |
Regulation |
denotes |
IFN-γ-mediated STAT1 activation [32] |
|
|
T21365 |
22668-22673 |
Protein |
denotes |
STAT1 |
|
|
T21422 |
22732-22789 |
Positive_regulation |
denotes |
in the defective IL-10-induced STAT3 activation of RA CD4 |
|
|
T21411 |
22739-22762 |
Protein |
denotes |
defective IL-10-induced |
|
|
T21395 |
22763-22768 |
Protein |
denotes |
STAT3 |
|
|
T21392 |
22780-22789 |
Protein |
denotes |
of RA CD4 |
|
|
T21409 |
22783-22785 |
Protein |
denotes |
RA |
|
|
T21394 |
22791-22798 |
Entity |
denotes |
T cells |
|
|
T21412 |
22814-22819 |
Protein |
denotes |
SOCS1 |
|
|
T21378 |
22814-22834 |
Protein |
denotes |
SOCS1 and SOCS3 mRNA |
|
|
T21421 |
22814-22914 |
Gene_expression |
denotes |
SOCS1 and SOCS3 mRNA expression in PB CD4+ T cells from active RA patients and from healthy controls |
|
|
T21420 |
22814-22914 |
Transcription |
denotes |
SOCS1 and SOCS3 mRNA expression in PB CD4+ T cells from active RA patients and from healthy controls |
|
|
T21370 |
22824-22829 |
Protein |
denotes |
SOCS3 |
|
|
T21390 |
22849-22851 |
Protein |
denotes |
PB |
|
|
T21372 |
22849-22864 |
Entity |
denotes |
PB CD4+ T cells |
|
|
T21368 |
22877-22879 |
Protein |
denotes |
RA |
|
|
T21374 |
22929-22962 |
Protein |
denotes |
by semiquantitative real-time PCR |
|
|
T21377 |
22964-22983 |
Entity |
denotes |
The RA CD4+ T cells |
|
|
T21367 |
22968-22970 |
Protein |
denotes |
RA |
|
|
T21363 |
23011-23016 |
Protein |
denotes |
SOCS1 |
|
|
T21383 |
23037-23042 |
Protein |
denotes |
SOCS3 |
|
|
T21387 |
23037-23054 |
Protein |
denotes |
SOCS3 transcripts |
|
|
T21369 |
23072-23094 |
Entity |
denotes |
CD4+ T cells (Fig. 6a) |
|
|
T21414 |
23109-23152 |
Gene_expression |
denotes |
expression of SOCS1 mRNA in RA CD4+ T cells |
|
|
T21399 |
23120-23133 |
Protein |
denotes |
of SOCS1 mRNA |
|
|
T21384 |
23123-23128 |
Protein |
denotes |
SOCS1 |
|
|
T21371 |
23137-23139 |
Protein |
denotes |
RA |
|
|
T21397 |
23137-23152 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T21406 |
23191-23238 |
Protein |
denotes |
normal CD4+ T cells stimulated by 10 ng/ml IL-6 |
|
|
T21418 |
23191-23239 |
Localization |
denotes |
normal CD4+ T cells stimulated by 10 ng/ml IL-6 |
|
|
T21393 |
23203-23210 |
Entity |
denotes |
T cells |
|
|
T21408 |
23240-23243 |
Protein |
denotes |
Fig |
|
|
T21403 |
23290-23305 |
Protein |
denotes |
Defective IL-10 |
|
|
T21402 |
23314-23319 |
Protein |
denotes |
STAT3 |
|
|
T21413 |
23314-23330 |
Positive_regulation |
denotes |
STAT3 activation |
|
|
T21373 |
23392-23400 |
Protein |
denotes |
of SOCS1 |
|
|
T21381 |
23404-23406 |
Protein |
denotes |
RA |
|
|
T21389 |
23404-23419 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T29887 |
23433-23445 |
Entity |
denotes |
CD4+ T cells |
|
|
T29982 |
23504-23511 |
Protein |
denotes |
RA [22] |
|
|
T29825 |
23513-23535 |
Entity |
denotes |
Activated CD4+ T cells |
|
|
T29785 |
23546-23557 |
Entity |
denotes |
macrophages |
|
|
T29780 |
23559-23579 |
Entity |
denotes |
synovial fibroblasts |
|
|
T29883 |
23581-23588 |
Entity |
denotes |
B cells |
|
|
T29964 |
23594-23605 |
Entity |
denotes |
osteoclasts |
|
|
T29749 |
23629-23644 |
Entity |
denotes |
of cell surface |
|
|
T29711 |
23645-23654 |
Entity |
denotes |
molecules |
|
|
T29756 |
23659-23673 |
Protein |
denotes |
Th1 cytokines, |
|
|
T29987 |
23755-23767 |
Entity |
denotes |
CD4+ T cells |
|
|
T29854 |
23805-23812 |
Entity |
denotes |
antigen |
|
|
T29787 |
23805-23821 |
Protein |
denotes |
antigen receptor |
|
|
T29860 |
23836-23849 |
Protein |
denotes |
CD28-mediated |
|
|
T30041 |
23836-23863 |
Regulation |
denotes |
CD28-mediated costimulation |
|
|
T29783 |
23868-23900 |
Protein |
denotes |
the ST lesion, the CD28 ligands, |
|
|
T29808 |
23883-23899 |
Entity |
denotes |
the CD28 ligands |
|
|
T29870 |
23887-23891 |
Protein |
denotes |
CD28 |
|
|
T29980 |
23906-23910 |
Protein |
denotes |
CD80 |
|
|
T29706 |
23915-23919 |
Protein |
denotes |
CD86 |
|
|
T29939 |
23935-23947 |
Protein |
denotes |
MHC class II |
|
|
T29923 |
23935-23956 |
Entity |
denotes |
MHC class II antigens |
|
|
T29905 |
23989-23996 |
Entity |
denotes |
antigen |
|
|
T29966 |
23997-24033 |
Entity |
denotes |
presenting cells such as macrophages |
|
|
T29823 |
24008-24021 |
Entity |
denotes |
cells such as |
|
|
T29683 |
24038-24061 |
Entity |
denotes |
dendritic cells [18-20] |
|
|
T29739 |
24080-24087 |
Protein |
denotes |
of CD28 |
|
|
T29713 |
24106-24121 |
Entity |
denotes |
T-cell-mediated |
|
|
T30017 |
24191-24272 |
Protein |
denotes |
its blocker cytotoxic T-cell-associated antigen 4 (CD152)-IgG in RA patients [23] |
|
|
T30001 |
24191-24272 |
Entity |
denotes |
its blocker cytotoxic T-cell-associated antigen 4 (CD152)-IgG in RA patients [23] |
|
|
T29850 |
24256-24258 |
Protein |
denotes |
RA |
|
|
T29704 |
24274-24279 |
Protein |
denotes |
IL-10 |
|
|
T29682 |
24386-24397 |
Entity |
denotes |
macrophages |
|
|
T29744 |
24402-24411 |
Entity |
denotes |
Th1 cells |
|
|
T29875 |
24417-24422 |
Protein |
denotes |
IL-10 |
|
|
T30099 |
24432-24481 |
Phosphorylation |
denotes |
the tyrosine phosphorylation of the CD28 molecule |
|
|
T29903 |
24436-24444 |
Entity |
denotes |
tyrosine |
|
|
T29979 |
24461-24481 |
Protein |
denotes |
of the CD28 molecule |
|
|
T29972 |
24542-24549 |
Entity |
denotes |
T cells |
|
|
T29769 |
24580-24592 |
Entity |
denotes |
T cells [24] |
|
|
T29994 |
24630-24632 |
Protein |
denotes |
PB |
|
|
T29800 |
24630-24675 |
Entity |
denotes |
PB CD4+ T cells from patients with active RA, |
|
|
T29853 |
24665-24674 |
Protein |
denotes |
active RA |
|
|
T29716 |
24695-24701 |
Protein |
denotes |
IL-10, |
|
|
T29732 |
24739-24744 |
Protein |
denotes |
IFN-γ |
|
|
T29695 |
24751-24754 |
Protein |
denotes |
CD3 |
|
|
T29985 |
24759-24763 |
Protein |
denotes |
CD28 |
|
|
T30037 |
24759-24777 |
Positive_regulation |
denotes |
CD28 costimulation |
|
|
T29986 |
24778-24802 |
Entity |
denotes |
than normal CD4+ T cells |
|
|
T29685 |
24823-24830 |
Protein |
denotes |
IL-10R1 |
|
|
T30050 |
24846-24876 |
Positive_regulation |
denotes |
constitutive STAT3 activation, |
|
|
T29691 |
24859-24864 |
Protein |
denotes |
STAT3 |
|
|
T29984 |
24877-24890 |
Protein |
denotes |
IL-10-induced |
|
|
T30040 |
24877-24924 |
Phosphorylation |
denotes |
IL-10-induced tyrosine phosphorylation of STAT3 |
|
|
T29760 |
24891-24899 |
Entity |
denotes |
tyrosine |
|
|
T29873 |
24916-24924 |
Protein |
denotes |
of STAT3 |
|
|
T30002 |
24942-24944 |
Protein |
denotes |
RA |
|
|
T29936 |
24942-24957 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T29858 |
24974-24984 |
Protein |
denotes |
normal CD4 |
|
|
T29726 |
24986-24993 |
Entity |
denotes |
T cells |
|
|
T29705 |
25001-25006 |
Protein |
denotes |
STAT3 |
|
|
T30105 |
25001-25022 |
Phosphorylation |
denotes |
STAT3 phosphorylation |
|
|
T30003 |
25056-25061 |
Protein |
denotes |
IL-10 |
|
|
T29672 |
25063-25073 |
Protein |
denotes |
Serum IL-6 |
|
|
T30112 |
25063-25157 |
Gene_expression |
denotes |
Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4+ T cells |
|
|
T30111 |
25063-25157 |
Positive_regulation |
denotes |
Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4+ T cells |
|
|
T29742 |
25079-25081 |
Protein |
denotes |
RA |
|
|
T29965 |
25099-25134 |
Protein |
denotes |
STAT3 but not STAT1 phosphorylation |
|
|
T29896 |
25113-25118 |
Protein |
denotes |
STAT1 |
|
|
T30029 |
25113-25134 |
Phosphorylation |
denotes |
STAT1 phosphorylation |
|
|
T29919 |
25138-25157 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T29945 |
25163-25177 |
Protein |
denotes |
exogenous IL-6 |
|
|
T29851 |
25204-25209 |
Protein |
denotes |
IL-10 |
|
|
T30026 |
25204-25240 |
Negative_regulation |
denotes |
IL-10 inhibition of IFN-γ production |
|
|
T30066 |
25221-25240 |
Gene_expression |
denotes |
of IFN-γ production |
|
|
T30007 |
25224-25229 |
Protein |
denotes |
IFN-γ |
|
|
T30005 |
25242-25244 |
Protein |
denotes |
RA |
|
|
T29673 |
25242-25257 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T29799 |
25283-25288 |
Protein |
denotes |
SOCS1 |
|
|
T29734 |
25317-25322 |
Protein |
denotes |
SOCS3 |
|
|
T29819 |
25317-25334 |
Protein |
denotes |
SOCS3 transcripts |
|
|
T29871 |
25354-25373 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T29772 |
25404-25416 |
Entity |
denotes |
CD4+ T cells |
|
|
T29988 |
25459-25467 |
Protein |
denotes |
of IL-10 |
|
|
T29688 |
25490-25506 |
Protein |
denotes |
the inflamed ST, |
|
|
T30061 |
25563-25587 |
Negative_regulation |
denotes |
impaired IL-10-dependent |
|
|
T29956 |
25563-25587 |
Protein |
denotes |
impaired IL-10-dependent |
|
|
T30067 |
25563-25667 |
Positive_regulation |
denotes |
impaired IL-10-dependent STAT3 activation, in association with sustained STAT3 phosphorylation and SOCS1 |
|
|
T30035 |
25563-25667 |
Regulation |
denotes |
impaired IL-10-dependent STAT3 activation, in association with sustained STAT3 phosphorylation and SOCS1 |
|
|
T29999 |
25588-25593 |
Protein |
denotes |
STAT3 |
|
|
T30045 |
25626-25657 |
Phosphorylation |
denotes |
sustained STAT3 phosphorylation |
|
|
T29872 |
25636-25641 |
Protein |
denotes |
STAT3 |
|
|
T29699 |
25662-25667 |
Protein |
denotes |
SOCS1 |
|
|
T29709 |
25679-25693 |
Protein |
denotes |
IL-10-mediated |
|
|
T30108 |
25679-25739 |
Regulation |
denotes |
IL-10-mediated inhibition of CD4+ T-cell cytokine production |
|
|
T30025 |
25679-25815 |
Regulation |
denotes |
IL-10-mediated inhibition of CD4+ T-cell cytokine production is principally dependent on its inhibition of macrophage antigen-presenting |
|
|
T29741 |
25705-25739 |
Entity |
denotes |
of CD4+ T-cell cytokine production |
|
|
T29948 |
25783-25815 |
Entity |
denotes |
of macrophage antigen-presenting |
|
|
T30014 |
25786-25796 |
Entity |
denotes |
macrophage |
|
|
T29943 |
25816-25820 |
Entity |
denotes |
cell |
|
|
T29963 |
25919-25925 |
Entity |
denotes |
T-cell |
|
|
T29997 |
25940-25942 |
Protein |
denotes |
RA |
|
|
T29813 |
25952-25973 |
Entity |
denotes |
macrophages in the ST |
|
|
T29932 |
25967-25973 |
Protein |
denotes |
the ST |
|
|
T29747 |
25997-26006 |
Protein |
denotes |
cytokines |
|
|
T29842 |
25997-26032 |
Entity |
denotes |
cytokines, CD80 and CD86 molecules, |
|
|
T29941 |
26008-26012 |
Protein |
denotes |
CD80 |
|
|
T29798 |
26017-26021 |
Protein |
denotes |
CD86 |
|
|
T29927 |
26037-26049 |
Protein |
denotes |
MHC class II |
|
|
T30006 |
26037-26058 |
Entity |
denotes |
MHC class II antigens |
|
|
T29668 |
26086-26091 |
Protein |
denotes |
IL-10 |
|
|
T29852 |
26121-26137 |
Entity |
denotes |
antigen-specific |
|
|
T29778 |
26138-26144 |
Entity |
denotes |
T-cell |
|
|
T30059 |
26165-26210 |
Negative_regulation |
denotes |
inhibiting CD28 tyrosine phosphorylation [33] |
|
|
T29786 |
26176-26180 |
Protein |
denotes |
CD28 |
|
|
T29720 |
26176-26210 |
Entity |
denotes |
CD28 tyrosine phosphorylation [33] |
|
|
T30082 |
26212-26273 |
Negative_regulation |
denotes |
This direct effect also may be limited in active RA patients, |
|
true |
T29755 |
26261-26263 |
Protein |
denotes |
RA |
|
|
T29954 |
26288-26290 |
Protein |
denotes |
PB |
|
|
T29840 |
26288-26294 |
Protein |
denotes |
PB CD4 |
|
|
T29951 |
26296-26303 |
Entity |
denotes |
T cells |
|
|
T30022 |
26296-26394 |
Negative_regulation |
denotes |
T cells showed a defective IL-10 inhibition of CD28-costimulated production of both IFN-γ and IL-2 |
|
|
T30021 |
26296-26394 |
Negative_regulation |
denotes |
T cells showed a defective IL-10 inhibition of CD28-costimulated production of both IFN-γ and IL-2 |
|
|
T29992 |
26323-26328 |
Protein |
denotes |
IL-10 |
|
|
T30086 |
26340-26394 |
Positive_regulation |
denotes |
of CD28-costimulated production of both IFN-γ and IL-2 |
|
|
T30085 |
26340-26394 |
Positive_regulation |
denotes |
of CD28-costimulated production of both IFN-γ and IL-2 |
|
|
T30028 |
26340-26394 |
Gene_expression |
denotes |
of CD28-costimulated production of both IFN-γ and IL-2 |
|
|
T30027 |
26340-26394 |
Gene_expression |
denotes |
of CD28-costimulated production of both IFN-γ and IL-2 |
|
|
T29947 |
26343-26360 |
Protein |
denotes |
CD28-costimulated |
|
|
T29915 |
26380-26385 |
Protein |
denotes |
IFN-γ |
|
|
T29920 |
26390-26394 |
Protein |
denotes |
IL-2 |
|
|
T30010 |
26396-26495 |
Protein |
denotes |
Numerous cytokines, both proinflammatory and anti-inflammatory, have been detected in the ST of RA, |
|
|
T29848 |
26482-26494 |
Protein |
denotes |
the ST of RA |
|
|
T29729 |
26492-26494 |
Protein |
denotes |
RA |
|
|
T30090 |
26588-26614 |
Gene_expression |
denotes |
Endogenous IL-10, produced |
|
|
T29834 |
26588-26614 |
Protein |
denotes |
Endogenous IL-10, produced |
|
|
T29977 |
26625-26636 |
Entity |
denotes |
macrophages |
|
|
T29892 |
26641-26648 |
Entity |
denotes |
T cells |
|
|
T29697 |
26698-26700 |
Protein |
denotes |
ST |
|
|
T29836 |
26698-26711 |
Entity |
denotes |
ST cells [12] |
|
|
T29890 |
26822-26916 |
Entity |
denotes |
the extracellular stimulus-regulated kinase and p38 kinase pathways, induced by TNF-α and IL-1 |
|
|
T29995 |
26840-26865 |
Protein |
denotes |
stimulus-regulated kinase |
|
|
T29718 |
26870-26873 |
Protein |
denotes |
p38 |
|
|
T29930 |
26870-26890 |
Protein |
denotes |
p38 kinase pathways, |
|
|
T29674 |
26902-26907 |
Protein |
denotes |
TNF-α |
|
|
T29754 |
26912-26916 |
Protein |
denotes |
IL-1 |
|
|
T29867 |
26927-26984 |
Protein |
denotes |
the Jak1–STAT3 signaling pathway shared by IL-10 and IL-6 |
|
|
T29894 |
26936-26941 |
Protein |
denotes |
STAT3 |
|
|
T29746 |
26970-26975 |
Protein |
denotes |
IL-10 |
|
|
T29686 |
26980-26984 |
Protein |
denotes |
IL-6 |
|
|
T29885 |
26996-27012 |
Entity |
denotes |
macrophages [13] |
|
|
T29667 |
27032-27046 |
Protein |
denotes |
IL-10-mediated |
|
|
T30068 |
27032-27063 |
Positive_regulation |
denotes |
IL-10-mediated STAT3 activation |
|
|
T30054 |
27032-27063 |
Regulation |
denotes |
IL-10-mediated STAT3 activation |
|
|
T29809 |
27047-27052 |
Protein |
denotes |
STAT3 |
|
|
T29924 |
27090-27092 |
Protein |
denotes |
RA |
|
|
T29893 |
27090-27113 |
Entity |
denotes |
RA synovial macrophages |
|
|
T30106 |
27115-27144 |
Positive_regulation |
denotes |
This impaired IL-10 signaling |
|
|
T30098 |
27115-27144 |
Negative_regulation |
denotes |
This impaired IL-10 signaling |
|
|
T29679 |
27129-27134 |
Protein |
denotes |
IL-10 |
|
|
T29770 |
27188-27213 |
Entity |
denotes |
immune complexes in vivo, |
|
|
T29703 |
27227-27258 |
Entity |
denotes |
cell surface IL-10R1 expression |
|
|
T29931 |
27240-27247 |
Protein |
denotes |
IL-10R1 |
|
|
T29829 |
27263-27276 |
Protein |
denotes |
IL-10-induced |
|
|
T30024 |
27263-27292 |
Positive_regulation |
denotes |
IL-10-induced Jak1 activation |
|
|
T29751 |
27277-27281 |
Protein |
denotes |
Jak1 |
|
|
T29675 |
27311-27375 |
Entity |
denotes |
IFN-γ-primed macrophages by a protein kinase C-dependent pathway |
|
|
T29849 |
27341-27367 |
Protein |
denotes |
protein kinase C-dependent |
|
|
T29795 |
27398-27404 |
Protein |
denotes |
the Ig |
|
|
T29888 |
27415-27428 |
Protein |
denotes |
receptor [14] |
|
|
T29816 |
27443-27458 |
Entity |
denotes |
dendritic cells |
|
|
T29759 |
27464-27466 |
Protein |
denotes |
RA |
|
|
T29991 |
27528-27536 |
Protein |
denotes |
of IL-10 |
|
|
T29961 |
27564-27588 |
Protein |
denotes |
of intracellular IL-10R1 |
|
|
T30062 |
27564-27589 |
Localization |
denotes |
of intracellular IL-10R1 |
|
|
T29864 |
27567-27580 |
Entity |
denotes |
intracellular |
|
|
T29913 |
27624-27632 |
Protein |
denotes |
cytokine |
|
|
T29899 |
27633-27719 |
Protein |
denotes |
stimuli such as TNF-α, IL-1, and granulocyte–macrophage colony-stimulating factor [15] |
|
|
T29882 |
27656-27661 |
Protein |
denotes |
IL-1, |
|
|
T29929 |
27666-27719 |
Protein |
denotes |
granulocyte–macrophage colony-stimulating factor [15] |
|
|
T29946 |
27762-27771 |
Protein |
denotes |
of RA CD4 |
|
|
T29696 |
27765-27767 |
Protein |
denotes |
RA |
|
|
T29731 |
27773-27780 |
Entity |
denotes |
T cells |
|
|
T30042 |
27773-27888 |
Positive_regulation |
denotes |
T cells to IL-10 may be associated with defective IL-10-dependent STAT3 activation, but not with IL-10R1 expression |
|
|
T29681 |
27784-27789 |
Protein |
denotes |
IL-10 |
|
|
T30023 |
27808-27888 |
Regulation |
denotes |
with defective IL-10-dependent STAT3 activation, but not with IL-10R1 expression |
|
|
T29815 |
27813-27838 |
Protein |
denotes |
defective IL-10-dependent |
|
|
T29721 |
27839-27844 |
Protein |
denotes |
STAT3 |
|
|
T29839 |
27870-27877 |
Protein |
denotes |
IL-10R1 |
|
|
T30096 |
27870-27888 |
Gene_expression |
denotes |
IL-10R1 expression |
|
|
T30016 |
27912-27917 |
Protein |
denotes |
IL-10 |
|
|
T29752 |
27927-27944 |
Entity |
denotes |
inflammatory cell |
|
|
T29880 |
28061-28063 |
Protein |
denotes |
RA |
|
|
T30076 |
28080-28125 |
Regulation |
denotes |
with impaired IL-10-mediated STAT3 activation |
|
|
T30030 |
28080-28125 |
Positive_regulation |
denotes |
with impaired IL-10-mediated STAT3 activation |
|
|
T30063 |
28085-28108 |
Negative_regulation |
denotes |
impaired IL-10-mediated |
|
|
T29960 |
28085-28108 |
Protein |
denotes |
impaired IL-10-mediated |
|
|
T30004 |
28109-28114 |
Protein |
denotes |
STAT3 |
|
|
T29730 |
28127-28132 |
Protein |
denotes |
STAT3 |
|
|
T29766 |
28149-28157 |
Entity |
denotes |
tyrosine |
|
|
T29764 |
28222-28224 |
Protein |
denotes |
PB |
|
|
T29768 |
28222-28244 |
Entity |
denotes |
PB and ST CD4+ T cells |
|
|
T29820 |
28229-28236 |
Protein |
denotes |
ST CD4+ |
|
|
T29938 |
28250-28252 |
Protein |
denotes |
RA |
|
|
T29806 |
28263-28268 |
Protein |
denotes |
STAT3 |
|
|
T30113 |
28263-28281 |
Positive_regulation |
denotes |
STAT3 is activated |
|
|
T29811 |
28295-28308 |
Protein |
denotes |
of cytokines, |
|
|
T30018 |
28321-28325 |
Protein |
denotes |
IL-6 |
|
|
T29690 |
28336-28410 |
Protein |
denotes |
cytokines (e.g. IL-6, IL-11, leukemia inhibitory factor, and oncostatin M) |
|
|
T29916 |
28352-28356 |
Protein |
denotes |
IL-6 |
|
|
T29684 |
28358-28363 |
Protein |
denotes |
IL-11 |
|
|
T29918 |
28365-28391 |
Protein |
denotes |
leukemia inhibitory factor |
|
|
T29865 |
28397-28409 |
Protein |
denotes |
oncostatin M |
|
|
T29790 |
28446-28455 |
Protein |
denotes |
IL-10 [4] |
|
|
T29832 |
28460-28476 |
Protein |
denotes |
these cytokines, |
|
|
T29810 |
28477-28481 |
Protein |
denotes |
IL-6 |
|
|
T29758 |
28576-28586 |
Protein |
denotes |
active RA, |
|
|
T29967 |
28675-28679 |
Protein |
denotes |
IL-6 |
|
|
T29750 |
28751-28753 |
Protein |
denotes |
RA |
|
|
T29998 |
28787-28795 |
Protein |
denotes |
to IL-10 |
|
|
T29847 |
28814-28833 |
Entity |
denotes |
normal CD4+ T cells |
|
|
T29670 |
28868-28872 |
Protein |
denotes |
IL-6 |
|
|
T29959 |
28920-28925 |
Protein |
denotes |
STAT3 |
|
|
T30114 |
28920-28936 |
Positive_regulation |
denotes |
STAT3 activation |
|
|
T29877 |
28959-28964 |
Protein |
denotes |
IL-10 |
|
|
T30103 |
28959-28975 |
Negative_regulation |
denotes |
IL-10 inhibition |
|
|
T29822 |
28985-28987 |
Protein |
denotes |
RA |
|
|
T29827 |
28985-29000 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T29957 |
29079-29083 |
Protein |
denotes |
IL-6 |
|
|
T29866 |
29114-29124 |
Protein |
denotes |
that STAT3 |
|
|
T29928 |
29169-29181 |
Entity |
denotes |
CD4+ T cells |
|
|
T29774 |
29195-29200 |
Protein |
denotes |
IL-10 |
|
|
T29793 |
29250-29265 |
Protein |
denotes |
exogenous IL-10 |
|
|
T29773 |
29275-29277 |
Protein |
denotes |
RA |
|
|
T29971 |
29275-29300 |
Entity |
denotes |
RA CD4+ T cells in the ST |
|
|
T29969 |
29294-29300 |
Protein |
denotes |
the ST |
|
|
T29974 |
29348-29358 |
Protein |
denotes |
IL-10 [34] |
|
|
T29970 |
29360-29399 |
Entity |
denotes |
CD4+ T cells isolated from the ST of RA |
|
|
T29990 |
29382-29399 |
Protein |
denotes |
from the ST of RA |
|
|
T29855 |
29397-29399 |
Protein |
denotes |
RA |
|
|
T29803 |
29428-29441 |
Protein |
denotes |
IL-10-induced |
|
|
T29910 |
29442-29447 |
Protein |
denotes |
STAT3 |
|
|
T30008 |
29507-29522 |
Entity |
denotes |
of CD4+ T cells |
|
|
T29745 |
29526-29531 |
Protein |
denotes |
IL-10 |
|
|
T29983 |
29575-29591 |
Protein |
denotes |
the inflamed ST, |
|
|
T29814 |
29600-29604 |
Protein |
denotes |
IL-6 |
|
|
T29942 |
29728-29737 |
Protein |
denotes |
cytokines |
|
|
T29775 |
29818-29832 |
Protein |
denotes |
IL-10-mediated |
|
|
T30094 |
29818-29865 |
Regulation |
denotes |
IL-10-mediated IFN-γ inhibition in CD4+ T cells |
|
|
T30038 |
29818-29865 |
Negative_regulation |
denotes |
IL-10-mediated IFN-γ inhibition in CD4+ T cells |
|
|
T29728 |
29833-29838 |
Protein |
denotes |
IFN-γ |
|
|
T29968 |
29853-29865 |
Entity |
denotes |
CD4+ T cells |
|
|
T29879 |
29899-29904 |
Protein |
denotes |
IL-1β |
|
|
T29762 |
29909-29914 |
Protein |
denotes |
TNF-α |
|
|
T29781 |
29950-29971 |
Protein |
denotes |
IL-6 (data not shown) |
|
|
T29693 |
29986-29991 |
Protein |
denotes |
IFN-γ |
|
|
T30084 |
29996-30026 |
Gene_expression |
denotes |
IL-10 produced by CD4+ T cells |
|
|
T29784 |
29996-30026 |
Protein |
denotes |
IL-10 produced by CD4+ T cells |
|
|
T29868 |
30011-30026 |
Entity |
denotes |
by CD4+ T cells |
|
|
T30097 |
30059-30098 |
Positive_regulation |
denotes |
for impaired IL-10 signaling in the ST, |
|
|
T30047 |
30059-30098 |
Negative_regulation |
denotes |
for impaired IL-10 signaling in the ST, |
|
|
T30015 |
30072-30077 |
Protein |
denotes |
IL-10 |
|
|
T29937 |
30091-30097 |
Protein |
denotes |
the ST |
|
|
T29861 |
30107-30113 |
Entity |
denotes |
T-cell |
|
|
T29789 |
30134-30156 |
Protein |
denotes |
both cytokines [34,35] |
|
|
T29689 |
30183-30188 |
Protein |
denotes |
IL-10 |
|
|
T30049 |
30183-30232 |
Positive_regulation |
denotes |
IL-10 may persistently stimulate STAT3 activation |
|
true |
T29792 |
30216-30221 |
Protein |
denotes |
STAT3 |
|
|
T30093 |
30216-30232 |
Positive_regulation |
denotes |
STAT3 activation |
|
|
T29733 |
30237-30242 |
Protein |
denotes |
IFN-γ |
|
|
T30075 |
30237-30267 |
Gene_expression |
denotes |
IFN-γ can induce SOCS1 protein |
|
true |
T30074 |
30237-30267 |
Positive_regulation |
denotes |
IFN-γ can induce SOCS1 protein |
|
true |
T29895 |
30254-30259 |
Protein |
denotes |
SOCS1 |
|
|
T29909 |
30254-30267 |
Protein |
denotes |
SOCS1 protein |
|
|
T29856 |
30283-30316 |
Entity |
denotes |
inhibitor of IL-10 signaling [32] |
|
|
T30019 |
30296-30301 |
Protein |
denotes |
IL-10 |
|
|
T30095 |
30296-30316 |
Positive_regulation |
denotes |
IL-10 signaling [32] |
|
|
T30083 |
30318-30455 |
Regulation |
denotes |
The T-cell-inhibitory effect of IL-10 may therefore be modulated complicatedly upon exposure to an inflammatory environment in RA joints, |
|
true |
T29949 |
30347-30355 |
Protein |
denotes |
of IL-10 |
|
|
T29700 |
30445-30447 |
Protein |
denotes |
RA |
|
|
T29978 |
30462-30476 |
Protein |
denotes |
many cytokines |
|
|
T29940 |
30509-30514 |
Protein |
denotes |
STAT3 |
|
|
T30101 |
30509-30525 |
Positive_regulation |
denotes |
STAT3 activation |
|
|
T29862 |
30569-30571 |
Protein |
denotes |
RA |
|
|
T29801 |
30573-30585 |
Protein |
denotes |
Active STAT3 |
|
|
T30053 |
30573-30671 |
Gene_expression |
denotes |
Active STAT3 is constitutively expressed in synovial fluid mononuclear cells from RA patients [36] |
|
|
T29723 |
30617-30649 |
Entity |
denotes |
synovial fluid mononuclear cells |
|
|
T29859 |
30655-30657 |
Protein |
denotes |
RA |
|
|
T29891 |
30673-30677 |
Protein |
denotes |
IL-6 |
|
|
T29835 |
30681-30740 |
Protein |
denotes |
the major STAT3-activating factor present in synovial fluid |
|
|
T30056 |
30785-30875 |
Gene_expression |
denotes |
of monocyte functions such as gene expression of the Fc gamma receptor type I and type III |
|
|
T30055 |
30785-30875 |
Gene_expression |
denotes |
of monocyte functions such as gene expression of the Fc gamma receptor type I and type III |
|
|
T29735 |
30788-30796 |
Entity |
denotes |
monocyte |
|
|
T29771 |
30834-30862 |
Protein |
denotes |
the Fc gamma receptor type I |
|
|
T29837 |
30867-30875 |
Protein |
denotes |
type III |
|
|
T29694 |
30936-30941 |
Protein |
denotes |
STAT3 |
|
|
T29692 |
30975-30980 |
Protein |
denotes |
IL-6, |
|
|
T29917 |
31003-31009 |
Protein |
denotes |
the ST |
|
|
T29976 |
31015-31020 |
Protein |
denotes |
STAT3 |
|
|
T30104 |
31015-31123 |
Positive_regulation |
denotes |
STAT3 activation has been shown to be involved in synovial fibroblast proliferation and IL-6 production [37] |
|
|
T29944 |
31103-31107 |
Protein |
denotes |
IL-6 |
|
|
T30036 |
31103-31123 |
Gene_expression |
denotes |
IL-6 production [37] |
|
|
T29796 |
31141-31146 |
Protein |
denotes |
STAT3 |
|
|
T30011 |
31189-31241 |
Entity |
denotes |
of growth factor-dependent synovial fibroblasts [38] |
|
|
T29846 |
31192-31215 |
Protein |
denotes |
growth factor-dependent |
|
|
T29680 |
31287-31292 |
Protein |
denotes |
STAT3 |
|
|
T30087 |
31287-31324 |
Positive_regulation |
denotes |
STAT3 signaling in Th1-cell-dominated |
|
|
T29911 |
31376-31403 |
Protein |
denotes |
of the gp130F759/F759 mice, |
|
|
T29935 |
31417-31420 |
Protein |
denotes |
Src |
|
|
T29710 |
31430-31441 |
Protein |
denotes |
phosphatase |
|
|
T29874 |
31457-31545 |
Protein |
denotes |
of gp130 (the transmembrane glycoprotein β subunit of the IL-6 family cytokine receptor) |
|
|
T29743 |
31467-31544 |
Protein |
denotes |
the transmembrane glycoprotein β subunit of the IL-6 family cytokine receptor |
|
|
T29950 |
31547-31559 |
Entity |
denotes |
tyrosine 759 |
|
|
T30012 |
31576-31594 |
Entity |
denotes |
phenylalanine [39] |
|
|
T29724 |
31618-31632 |
Protein |
denotes |
mice, T cells, |
|
|
T29838 |
31624-31631 |
Entity |
denotes |
T cells |
|
|
T29902 |
31655-31661 |
Entity |
denotes |
T-cell |
|
|
T29881 |
31751-31765 |
Protein |
denotes |
gp130-mediated |
|
|
T30107 |
31751-31782 |
Positive_regulation |
denotes |
gp130-mediated STAT3 activation |
|
|
T30100 |
31751-31782 |
Regulation |
denotes |
gp130-mediated STAT3 activation |
|
|
T29765 |
31766-31771 |
Protein |
denotes |
STAT3 |
|
|
T30013 |
31801-31809 |
Protein |
denotes |
cytokine |
|
|
T29958 |
31829-31852 |
Protein |
denotes |
by the JAK–STAT pathway |
|
|
T29776 |
31840-31844 |
Protein |
denotes |
STAT |
|
|
T29826 |
31866-31897 |
Protein |
denotes |
by the SOCS family proteins [7] |
|
|
T29676 |
31873-31877 |
Protein |
denotes |
SOCS |
|
|
T29748 |
31913-31954 |
Entity |
denotes |
CD4+ T cells from patients with active RA |
|
|
T29933 |
31945-31954 |
Protein |
denotes |
active RA |
|
|
T29828 |
31982-31987 |
Protein |
denotes |
SOCS1 |
|
|
T29981 |
32009-32015 |
Protein |
denotes |
SOCS3, |
|
|
T29926 |
32025-32049 |
Entity |
denotes |
with normal CD4+ T cells |
|
|
T29912 |
32051-32056 |
Protein |
denotes |
SOCS1 |
|
|
T30072 |
32051-32110 |
Negative_regulation |
denotes |
SOCS1 prevents activation of JAK by directly binding to JAK |
|
|
T30051 |
32051-32110 |
Binding |
denotes |
SOCS1 prevents activation of JAK by directly binding to JAK |
|
|
T30058 |
32066-32083 |
Positive_regulation |
denotes |
activation of JAK |
|
|
T29884 |
32077-32083 |
Protein |
denotes |
of JAK |
|
|
T29671 |
32104-32110 |
Protein |
denotes |
to JAK |
|
|
T29794 |
32116-32121 |
Protein |
denotes |
SOCS3 |
|
|
T30057 |
32116-32240 |
Binding |
denotes |
SOCS3 inhibits the action of JAK by binding to the Src homology phosphatase-2-binding domain of receptors such as gp130 [40] |
|
|
T29975 |
32142-32148 |
Protein |
denotes |
of JAK |
|
|
T29805 |
32160-32240 |
Entity |
denotes |
to the Src homology phosphatase-2-binding domain of receptors such as gp130 [40] |
|
|
T29908 |
32167-32170 |
Protein |
denotes |
Src |
|
|
T29897 |
32212-32229 |
Protein |
denotes |
receptors such as |
|
|
T29876 |
32212-32240 |
Protein |
denotes |
receptors such as gp130 [40] |
|
|
T29952 |
32242-32247 |
Protein |
denotes |
SOCS1 |
|
|
T30034 |
32242-32380 |
Positive_regulation |
denotes |
SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7] |
|
|
T30033 |
32242-32380 |
Gene_expression |
denotes |
SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7] |
|
|
T30032 |
32242-32380 |
Positive_regulation |
denotes |
SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7] |
|
|
T30031 |
32242-32380 |
Gene_expression |
denotes |
SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7] |
|
|
T29701 |
32252-32257 |
Protein |
denotes |
SOCS3 |
|
|
T29886 |
32270-32317 |
Protein |
denotes |
by various cytokines, including IL-6 and IL-10, |
|
|
T29818 |
32302-32306 |
Protein |
denotes |
IL-6 |
|
|
T29725 |
32311-32316 |
Protein |
denotes |
IL-10 |
|
|
T29708 |
32402-32429 |
Protein |
denotes |
mice lacking SOCS3 or SOCS1 |
|
|
T29779 |
32415-32420 |
Protein |
denotes |
SOCS3 |
|
|
T29669 |
32424-32429 |
Protein |
denotes |
SOCS1 |
|
|
T29906 |
32444-32449 |
Protein |
denotes |
SOCS3 |
|
|
T29833 |
32477-32481 |
Protein |
denotes |
IL-6 |
|
|
T30060 |
32477-32491 |
Positive_regulation |
denotes |
IL-6 signaling |
|
|
T29698 |
32503-32508 |
Protein |
denotes |
IL-10 |
|
|
T30052 |
32503-32518 |
Positive_regulation |
denotes |
IL-10 signaling |
|
|
T29804 |
32528-32548 |
Protein |
denotes |
of conditional SOCS3 |
|
|
T29687 |
32549-32563 |
Protein |
denotes |
deficient mice |
|
|
T29767 |
32580-32623 |
Protein |
denotes |
SOCS3 deficiency, but not SOCS1 deficiency, |
|
|
T29831 |
32606-32623 |
Protein |
denotes |
SOCS1 deficiency, |
|
|
T29996 |
32659-32664 |
Protein |
denotes |
STAT3 |
|
|
T29817 |
32680-32684 |
Protein |
denotes |
IL-6 |
|
|
T29921 |
32709-32714 |
Protein |
denotes |
SOCS3 |
|
|
T29962 |
32715-32736 |
Entity |
denotes |
deficient macrophages |
|
|
T29737 |
32751-32761 |
Protein |
denotes |
that SOCS3 |
|
|
T29791 |
32765-32834 |
Entity |
denotes |
a crucial inhibitor of the IL-6-induced transcriptional response [42] |
|
|
T29841 |
32845-32850 |
Protein |
denotes |
SOCS3 |
|
|
T29973 |
32940-32948 |
Protein |
denotes |
of IL-10 |
|
|
T29922 |
32952-32968 |
Entity |
denotes |
macrophages [41] |
|
|
T30020 |
32970-33052 |
Negative_regulation |
denotes |
On the contrary, SOCS1 was found to directly inhibit IL-10-mediated signaling [43] |
|
|
T29934 |
32987-32992 |
Protein |
denotes |
SOCS1 |
|
|
T29807 |
33023-33037 |
Protein |
denotes |
IL-10-mediated |
|
|
T30102 |
33023-33052 |
Regulation |
denotes |
IL-10-mediated signaling [43] |
|
|
T29797 |
33064-33069 |
Protein |
denotes |
SOCS1 |
|
|
T30089 |
33064-33099 |
Gene_expression |
denotes |
SOCS1 expression in RA CD4+ T cells |
|
|
T30064 |
33064-33137 |
Binding |
denotes |
SOCS1 expression in RA CD4+ T cells may therefore be associated with both |
|
|
T29722 |
33084-33086 |
Protein |
denotes |
RA |
|
|
T29993 |
33084-33099 |
Entity |
denotes |
RA CD4+ T cells |
|
|
T29844 |
33169-33174 |
Protein |
denotes |
IL-10 |
|
|
T29845 |
33182-33196 |
Protein |
denotes |
IL-10-mediated |
|
|
T30077 |
33182-33214 |
Positive_regulation |
denotes |
IL-10-mediated STAT3 activation, |
|
|
T30048 |
33182-33214 |
Regulation |
denotes |
IL-10-mediated STAT3 activation, |
|
|
T29777 |
33197-33202 |
Protein |
denotes |
STAT3 |
|
|
T30039 |
33219-33245 |
Gene_expression |
denotes |
defective SOCS3 expression |
|
|
T29914 |
33229-33234 |
Protein |
denotes |
SOCS3 |
|
|
T30065 |
33265-33296 |
Positive_regulation |
denotes |
for persistent STAT3 activation |
|
|
T29869 |
33280-33285 |
Protein |
denotes |
STAT3 |
|
|
T29989 |
33318-33322 |
Protein |
denotes |
IL-6 |
|
|
T29857 |
33352-33357 |
Protein |
denotes |
SOCS1 |
|
|
T30110 |
33352-33367 |
Gene_expression |
denotes |
SOCS1 induction |
|
|
T30109 |
33352-33367 |
Positive_regulation |
denotes |
SOCS1 induction |
|
|
T29678 |
33403-33418 |
Entity |
denotes |
of CD4+ T cells |
|
|
T30080 |
33419-33435 |
Gene_expression |
denotes |
to produce IFN-γ |
|
|
T30000 |
33430-33435 |
Protein |
denotes |
IFN-γ |
|
|
T29900 |
33445-33472 |
Entity |
denotes |
CD4+ T cells from active RA |
|
|
T30009 |
33463-33472 |
Protein |
denotes |
active RA |
|
|
T29863 |
33502-33507 |
Protein |
denotes |
IFN-γ |
|
|
T29714 |
33527-33533 |
Protein |
denotes |
IL-10, |
|
|
T29821 |
33546-33551 |
Protein |
denotes |
IFN-γ |
|
|
T29707 |
33587-33595 |
Protein |
denotes |
of SOCS1 |
|
|
T29727 |
33670-33679 |
Entity |
denotes |
Th2 cells |
|
|
T29738 |
33703-33708 |
Protein |
denotes |
SOCS1 |
|
|
T29717 |
33713-33718 |
Protein |
denotes |
SOCS3 |
|
|
T29702 |
33713-33723 |
Protein |
denotes |
SOCS3 mRNA |
|
|
T29782 |
33744-33757 |
Protein |
denotes |
IL-12-induced |
|
|
T30081 |
33744-33774 |
Positive_regulation |
denotes |
IL-12-induced STAT4 activation |
|
|
T30070 |
33744-33820 |
Negative_regulation |
denotes |
IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells, |
|
|
T30069 |
33744-33820 |
Negative_regulation |
denotes |
IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells, |
|
|
T29889 |
33758-33763 |
Protein |
denotes |
STAT4 |
|
|
T30044 |
33788-33820 |
Gene_expression |
denotes |
by SOCS3 induction in Th2 cells, |
|
|
T30043 |
33788-33820 |
Positive_regulation |
denotes |
by SOCS3 induction in Th2 cells, |
|
|
T29740 |
33791-33796 |
Protein |
denotes |
SOCS3 |
|
|
T29753 |
33810-33819 |
Entity |
denotes |
Th2 cells |
|
|
T29843 |
33829-33841 |
Protein |
denotes |
IL-4-induced |
|
|
T30073 |
33829-33857 |
Positive_regulation |
denotes |
IL-4-induced STAT6 signaling |
|
|
T30092 |
33829-33903 |
Negative_regulation |
denotes |
IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells |
|
|
T30091 |
33829-33903 |
Negative_regulation |
denotes |
IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells |
|
|
T29898 |
33842-33847 |
Protein |
denotes |
STAT6 |
|
|
T30079 |
33872-33903 |
Positive_regulation |
denotes |
by SOCS1 induction in Th1 cells |
|
|
T30078 |
33872-33903 |
Gene_expression |
denotes |
by SOCS1 induction in Th1 cells |
|
|
T29736 |
33875-33880 |
Protein |
denotes |
SOCS1 |
|
|
T29824 |
33894-33903 |
Entity |
denotes |
Th1 cells |
|
|
T29878 |
33905-33910 |
Protein |
denotes |
SOCS1 |
|
|
T29761 |
33915-33920 |
Protein |
denotes |
SOCS3 |
|
|
T29955 |
34034-34044 |
Protein |
denotes |
IL-4–STAT6 |
|
|
T29953 |
34034-34044 |
Protein |
denotes |
IL-4–STAT6 |
|
|
T29925 |
34039-34044 |
Protein |
denotes |
STAT6 |
|
|
T29712 |
34053-34064 |
Protein |
denotes |
IL-12–STAT4 |
|
|
T29757 |
34053-34064 |
Protein |
denotes |
IL-12–STAT4 |
|
|
T29901 |
34059-34064 |
Protein |
denotes |
STAT4 |
|
|
T29719 |
34128-34130 |
Protein |
denotes |
PB |
|
|
T29907 |
34128-34175 |
Entity |
denotes |
PB T cells from patients with allergic diseases |
|
|
T29802 |
34213-34218 |
Protein |
denotes |
SOCS3 |
|
|
T29812 |
34213-34231 |
Protein |
denotes |
SOCS3 transcripts, |
|
|
T30071 |
34236-34256 |
Gene_expression |
denotes |
the SOCS3 expression |
|
|
T29830 |
34240-34245 |
Protein |
denotes |
SOCS3 |
|
|
T30046 |
34323-34346 |
Gene_expression |
denotes |
Higher SOCS1 expression |
|
|
T29715 |
34330-34335 |
Protein |
denotes |
SOCS1 |
|
|
T30088 |
34352-34374 |
Gene_expression |
denotes |
lower SOCS3 expression |
|
|
T29904 |
34358-34363 |
Protein |
denotes |
SOCS3 |
|
|
T29788 |
34378-34385 |
Protein |
denotes |
PB CD4+ |
|
|
T29677 |
34386-34393 |
Entity |
denotes |
T cells |
|
|
T29763 |
34399-34401 |
Protein |
denotes |
RA |
|
|
T31533 |
34584-34596 |
Entity |
denotes |
CD4+ T cells |
|
|
T31520 |
34609-34611 |
Protein |
denotes |
RA |
|
|
T31530 |
34662-34667 |
Protein |
denotes |
IL-10 |
|
|
T31548 |
34662-34741 |
Negative_regulation |
denotes |
IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation |
|
|
T31551 |
34679-34699 |
Gene_expression |
denotes |
of IFN-γ production, |
|
|
T31518 |
34682-34687 |
Protein |
denotes |
IFN-γ |
|
|
T31547 |
34707-34741 |
Phosphorylation |
denotes |
constitutive STAT3 phosphorylation |
|
|
T31531 |
34720-34725 |
Protein |
denotes |
STAT3 |
|
|
T31535 |
34755-34769 |
Protein |
denotes |
IL-10-mediated |
|
|
T31549 |
34755-34786 |
Regulation |
denotes |
IL-10-mediated STAT3 activation |
|
|
T31544 |
34755-34786 |
Positive_regulation |
denotes |
IL-10-mediated STAT3 activation |
|
|
T31525 |
34770-34775 |
Protein |
denotes |
STAT3 |
|
|
T31550 |
34788-34817 |
Positive_regulation |
denotes |
The defective STAT3 signaling |
|
|
T31536 |
34802-34807 |
Protein |
denotes |
STAT3 |
|
|
T31519 |
34846-34851 |
Protein |
denotes |
SOCS1 |
|
|
T31534 |
34870-34875 |
Protein |
denotes |
SOCS3 |
|
|
T31539 |
34900-34909 |
Protein |
denotes |
active RA |
|
|
T31522 |
34989-34996 |
Protein |
denotes |
of IL-6 |
|
|
T31521 |
35019-35027 |
Protein |
denotes |
of IL-10 |
|
|
T31526 |
35041-35043 |
Protein |
denotes |
RA |
|
|
T31537 |
35110-35138 |
Protein |
denotes |
IL-10 of inflammatory cells, |
|
|
T31538 |
35119-35138 |
Entity |
denotes |
inflammatory cells, |
|
|
T31532 |
35149-35156 |
Entity |
denotes |
T cells |
|
|
T31516 |
35252-35254 |
Protein |
denotes |
RA |
|
|
T31529 |
35329-35336 |
Entity |
denotes |
T cells |
|
|
T31542 |
35345-35394 |
Negative_regulation |
denotes |
the inhibition of IL-6-dependent STAT3 activation |
|
|
T31543 |
35360-35394 |
Regulation |
denotes |
of IL-6-dependent STAT3 activation |
|
|
T31541 |
35360-35394 |
Positive_regulation |
denotes |
of IL-6-dependent STAT3 activation |
|
|
T31527 |
35363-35377 |
Protein |
denotes |
IL-6-dependent |
|
|
T31517 |
35378-35383 |
Protein |
denotes |
STAT3 |
|
|
T31528 |
35428-35433 |
Protein |
denotes |
STAT3 |
|
|
T31540 |
35428-35444 |
Positive_regulation |
denotes |
STAT3 activation |
|
|
T31546 |
35475-35507 |
Positive_regulation |
denotes |
the induction of the SOCS3 gene, |
|
|
T31545 |
35475-35507 |
Gene_expression |
denotes |
the induction of the SOCS3 gene, |
|
|
T31524 |
35489-35506 |
Protein |
denotes |
of the SOCS3 gene |
|
|
T31523 |
35496-35501 |
Protein |
denotes |
SOCS3 |
|
|
R10018 |
T19706 |
T19794 |
themeOf |
STAT3,STAT3 is activated |
R10019 |
T19712 |
T19795 |
themeOf |
of STAT3,tyrosine phosphorylation of STAT3 but not STAT1 |
R10020 |
T19715 |
T19783 |
themeOf |
STAT1,STAT1 activation |
R10021 |
T19717 |
T19801 |
themeOf |
IL-10,IL-10 inhibition in active RA |
R10022 |
T19720 |
T19793 |
causeOf |
STAT1,STAT1 signaling |
R10023 |
T19723 |
T19792 |
themeOf |
STAT3,of STAT3 activation |
R10024 |
T19724 |
T19784 |
themeOf |
IFN-γ,the IFN-γ production |
R10025 |
T19725 |
T19782 |
causeOf |
IL-10-mediated,IL-10-mediated inhibition |
R10026 |
T19727 |
T19800 |
themeOf |
STAT3,STAT3 phosphorylation |
R10027 |
T19728 |
T19790 |
themeOf |
IFN-γ,IFN-γ production |
R10028 |
T19737 |
T19787 |
themeOf |
STAT1,of STAT1 activation |
R10029 |
T19740 |
T19798 |
themeOf |
STAT3,with STAT3 activation |
R10030 |
T19746 |
T19786 |
themeOf |
IFN-γ,IFN-γ production by CD4 |
R10031 |
T19754 |
T19712 |
partOf |
tyrosine,of STAT3 |
R10032 |
T19754 |
T19795 |
siteOf |
tyrosine,tyrosine phosphorylation of STAT3 but not STAT1 |
R10033 |
T19756 |
T19789 |
themeOf |
STAT3,this STAT3 activation |
R10034 |
T19764 |
T19796 |
themeOf |
of STAT3,constitutive activation of STAT3 in mononuclear cells [31] |
R10035 |
T19765 |
T19785 |
themeOf |
CD28,CD28 costimulation |
R10036 |
T19771 |
T19797 |
themeOf |
STAT,STAT phosphorylation was examined by western blot analysis |
R10037 |
T19773 |
T19791 |
causeOf |
IL-6,IL-6 could suppress the effect of IL-10 to inhibit IFN-γ production by CD4 |
R10038 |
T19786 |
T19799 |
themeOf |
IFN-γ production by CD4,inhibit IFN-γ production by CD4 |
R10803 |
T21362 |
T21417 |
themeOf |
of SOCS1 mRNA,High expression of SOCS1 mRNA in RA CD4+ T cells |
R10804 |
T21365 |
T21416 |
themeOf |
STAT1,IFN-γ-mediated STAT1 activation [32] |
R10805 |
T21378 |
T21420 |
themeOf |
SOCS1 and SOCS3 mRNA,SOCS1 and SOCS3 mRNA expression in PB CD4+ T cells from active RA patients and from healthy controls |
R10806 |
T21378 |
T21421 |
themeOf |
SOCS1 and SOCS3 mRNA,SOCS1 and SOCS3 mRNA expression in PB CD4+ T cells from active RA patients and from healthy controls |
R10807 |
T21386 |
T21415 |
causeOf |
IFN-γ-mediated,IFN-γ-mediated STAT1 activation [32] |
R10808 |
T21392 |
T21422 |
themeOf |
of RA CD4,in the defective IL-10-induced STAT3 activation of RA CD4 |
R10809 |
T21393 |
T21418 |
locationOf |
T cells,normal CD4+ T cells stimulated by 10 ng/ml IL-6 |
R10810 |
T21395 |
T21422 |
causeOf |
STAT3,in the defective IL-10-induced STAT3 activation of RA CD4 |
R10811 |
T21399 |
T21414 |
themeOf |
of SOCS1 mRNA,expression of SOCS1 mRNA in RA CD4+ T cells |
R10812 |
T21400 |
T21423 |
themeOf |
STAT3,IL-10-mediated STAT3 activation |
R10813 |
T21401 |
T21419 |
themeOf |
STAT3,STAT3 activation induced by IL-6 but not by IL-10 |
R10814 |
T21402 |
T21413 |
themeOf |
STAT3,STAT3 activation |
R10815 |
T21404 |
T21424 |
causeOf |
IL-10-mediated,IL-10-mediated STAT3 activation |
R10816 |
T21406 |
T21418 |
themeOf |
normal CD4+ T cells stimulated by 10 ng/ml IL-6,normal CD4+ T cells stimulated by 10 ng/ml IL-6 |
R10817 |
T21416 |
T21415 |
themeOf |
IFN-γ-mediated STAT1 activation [32],IFN-γ-mediated STAT1 activation [32] |
R10818 |
T21423 |
T21424 |
themeOf |
IL-10-mediated STAT3 activation,IL-10-mediated STAT3 activation |
R15936 |
T29667 |
T30054 |
causeOf |
IL-10-mediated,IL-10-mediated STAT3 activation |
R15940 |
T29671 |
T30051 |
themeOf |
to JAK,SOCS1 prevents activation of JAK by directly binding to JAK |
R15942 |
T29672 |
T30111 |
causeOf |
Serum IL-6,Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4+ T cells |
R15945 |
T29679 |
T30106 |
causeOf |
IL-10,This impaired IL-10 signaling |
R15946 |
T29680 |
T30087 |
causeOf |
STAT3,STAT3 signaling in Th1-cell-dominated |
R15949 |
T29689 |
T30049 |
causeOf |
IL-10,IL-10 may persistently stimulate STAT3 activation |
R15950 |
T29691 |
T30050 |
themeOf |
STAT3,"constitutive STAT3 activation," |
R15952 |
T29698 |
T30052 |
causeOf |
IL-10,IL-10 signaling |
R15955 |
T29701 |
T30031 |
themeOf |
SOCS3,"SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7]" |
R15956 |
T29701 |
T30034 |
themeOf |
SOCS3,"SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7]" |
R15959 |
T29705 |
T30105 |
themeOf |
STAT3,STAT3 phosphorylation |
R15961 |
T29709 |
T30108 |
causeOf |
IL-10-mediated,IL-10-mediated inhibition of CD4+ T-cell cytokine production |
R15964 |
T29715 |
T30046 |
themeOf |
SOCS1,Higher SOCS1 expression |
R15965 |
T29721 |
T30042 |
themeOf |
STAT3,"T cells to IL-10 may be associated with defective IL-10-dependent STAT3 activation, but not with IL-10R1 expression" |
R15967 |
T29751 |
T30024 |
themeOf |
Jak1,IL-10-induced Jak1 activation |
R15968 |
T29728 |
T30038 |
themeOf |
IFN-γ,IL-10-mediated IFN-γ inhibition in CD4+ T cells |
R15969 |
T29733 |
T30074 |
causeOf |
IFN-γ,IFN-γ can induce SOCS1 protein |
R15970 |
T29760 |
T29873 |
partOf |
tyrosine,of STAT3 |
R15971 |
T29736 |
T30078 |
themeOf |
SOCS1,by SOCS1 induction in Th1 cells |
R15972 |
T29736 |
T30079 |
themeOf |
SOCS1,by SOCS1 induction in Th1 cells |
R15973 |
T29740 |
T30043 |
themeOf |
SOCS3,"by SOCS3 induction in Th2 cells," |
R15974 |
T29740 |
T30044 |
themeOf |
SOCS3,"by SOCS3 induction in Th2 cells," |
R15975 |
T29760 |
T30040 |
siteOf |
tyrosine,IL-10-induced tyrosine phosphorylation of STAT3 |
R15976 |
T29765 |
T30107 |
themeOf |
STAT3,gp130-mediated STAT3 activation |
R15977 |
T29815 |
T30023 |
causeOf |
defective IL-10-dependent,"with defective IL-10-dependent STAT3 activation, but not with IL-10R1 expression" |
R15978 |
T29771 |
T30056 |
themeOf |
the Fc gamma receptor type I,of monocyte functions such as gene expression of the Fc gamma receptor type I and type III |
R15979 |
T29775 |
T30094 |
causeOf |
IL-10-mediated,IL-10-mediated IFN-γ inhibition in CD4+ T cells |
R15980 |
T29777 |
T30077 |
themeOf |
STAT3,"IL-10-mediated STAT3 activation," |
R15981 |
T29830 |
T30071 |
themeOf |
SOCS3,the SOCS3 expression |
R15982 |
T29833 |
T30060 |
causeOf |
IL-6,IL-6 signaling |
R15983 |
T29834 |
T30090 |
themeOf |
"Endogenous IL-10, produced","Endogenous IL-10, produced" |
R15984 |
T29784 |
T30084 |
themeOf |
IL-10 produced by CD4+ T cells,IL-10 produced by CD4+ T cells |
R15985 |
T29837 |
T30055 |
themeOf |
type III,of monocyte functions such as gene expression of the Fc gamma receptor type I and type III |
R15986 |
T29839 |
T30096 |
themeOf |
IL-10R1,IL-10R1 expression |
R15987 |
T29845 |
T30048 |
causeOf |
IL-10-mediated,"IL-10-mediated STAT3 activation," |
R15988 |
T29792 |
T30093 |
themeOf |
STAT3,STAT3 activation |
R15989 |
T29851 |
T30026 |
causeOf |
IL-10,IL-10 inhibition of IFN-γ production |
R15990 |
T29794 |
T30057 |
themeOf |
SOCS3,SOCS3 inhibits the action of JAK by binding to the Src homology phosphatase-2-binding domain of receptors such as gp130 [40] |
R15991 |
T29797 |
T30089 |
themeOf |
SOCS1,SOCS1 expression in RA CD4+ T cells |
R15992 |
T29857 |
T30109 |
themeOf |
SOCS1,SOCS1 induction |
R15993 |
T29857 |
T30110 |
themeOf |
SOCS1,SOCS1 induction |
R15994 |
T29860 |
T30041 |
causeOf |
CD28-mediated,CD28-mediated costimulation |
R15995 |
T29801 |
T30053 |
themeOf |
Active STAT3,Active STAT3 is constitutively expressed in synovial fluid mononuclear cells from RA patients [36] |
R15996 |
T29864 |
T30062 |
locationOf |
intracellular,of intracellular IL-10R1 |
R15997 |
T29806 |
T30113 |
themeOf |
STAT3,STAT3 is activated |
R15998 |
T29869 |
T30065 |
themeOf |
STAT3,for persistent STAT3 activation |
R15999 |
T29872 |
T30045 |
themeOf |
STAT3,sustained STAT3 phosphorylation |
R16000 |
T29873 |
T30040 |
themeOf |
of STAT3,IL-10-induced tyrosine phosphorylation of STAT3 |
R16001 |
T29807 |
T30102 |
causeOf |
IL-10-mediated,IL-10-mediated signaling [43] |
R16002 |
T29809 |
T30068 |
themeOf |
STAT3,IL-10-mediated STAT3 activation |
R16003 |
T29877 |
T30103 |
themeOf |
IL-10,IL-10 inhibition |
R16004 |
T29889 |
T30081 |
themeOf |
STAT4,IL-12-induced STAT4 activation |
R16005 |
T29881 |
T30100 |
causeOf |
gp130-mediated,gp130-mediated STAT3 activation |
R16006 |
T29884 |
T30058 |
themeOf |
of JAK,activation of JAK |
R16007 |
T29886 |
T30032 |
causeOf |
"by various cytokines, including IL-6 and IL-10,","SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7]" |
R16008 |
T29886 |
T30034 |
causeOf |
"by various cytokines, including IL-6 and IL-10,","SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7]" |
R16009 |
T29896 |
T30029 |
themeOf |
STAT1,STAT1 phosphorylation |
R16010 |
T29898 |
T30073 |
causeOf |
STAT6,IL-4-induced STAT6 signaling |
R16011 |
T29992 |
T30021 |
causeOf |
IL-10,T cells showed a defective IL-10 inhibition of CD28-costimulated production of both IFN-γ and IL-2 |
R16012 |
T29992 |
T30022 |
causeOf |
IL-10,T cells showed a defective IL-10 inhibition of CD28-costimulated production of both IFN-γ and IL-2 |
R16013 |
T29903 |
T29979 |
partOf |
tyrosine,of the CD28 molecule |
R16014 |
T29999 |
T30067 |
themeOf |
STAT3,"impaired IL-10-dependent STAT3 activation, in association with sustained STAT3 phosphorylation and SOCS1" |
R16015 |
T30000 |
T30080 |
themeOf |
IFN-γ,to produce IFN-γ |
R16016 |
T29903 |
T30099 |
siteOf |
tyrosine,the tyrosine phosphorylation of the CD28 molecule |
R16017 |
T30004 |
T30030 |
themeOf |
STAT3,with impaired IL-10-mediated STAT3 activation |
R16018 |
T29904 |
T30088 |
themeOf |
SOCS3,lower SOCS3 expression |
R16019 |
T30007 |
T30066 |
themeOf |
IFN-γ,of IFN-γ production |
R16020 |
T29909 |
T30074 |
themeOf |
SOCS1 protein,IFN-γ can induce SOCS1 protein |
R16021 |
T29909 |
T30075 |
themeOf |
SOCS1 protein,IFN-γ can induce SOCS1 protein |
R16022 |
T30015 |
T30097 |
causeOf |
IL-10,"for impaired IL-10 signaling in the ST," |
R16023 |
T29912 |
T30051 |
themeOf |
SOCS1,SOCS1 prevents activation of JAK by directly binding to JAK |
R16024 |
T30019 |
T30095 |
causeOf |
IL-10,IL-10 signaling [32] |
R16025 |
T29914 |
T30039 |
themeOf |
SOCS3,defective SOCS3 expression |
R16026 |
T29915 |
T30028 |
themeOf |
IFN-γ,of CD28-costimulated production of both IFN-γ and IL-2 |
R16027 |
T30027 |
T30021 |
themeOf |
of CD28-costimulated production of both IFN-γ and IL-2,T cells showed a defective IL-10 inhibition of CD28-costimulated production of both IFN-γ and IL-2 |
R16028 |
T30027 |
T30086 |
themeOf |
of CD28-costimulated production of both IFN-γ and IL-2,of CD28-costimulated production of both IFN-γ and IL-2 |
R16029 |
T29920 |
T30027 |
themeOf |
IL-2,of CD28-costimulated production of both IFN-γ and IL-2 |
R16030 |
T30028 |
T30022 |
themeOf |
of CD28-costimulated production of both IFN-γ and IL-2,T cells showed a defective IL-10 inhibition of CD28-costimulated production of both IFN-γ and IL-2 |
R16031 |
T30028 |
T30085 |
themeOf |
of CD28-costimulated production of both IFN-γ and IL-2,of CD28-costimulated production of both IFN-γ and IL-2 |
R16032 |
T30030 |
T30076 |
themeOf |
with impaired IL-10-mediated STAT3 activation,with impaired IL-10-mediated STAT3 activation |
R16033 |
T29940 |
T30101 |
themeOf |
STAT3,STAT3 activation |
R16034 |
T30038 |
T30094 |
themeOf |
IL-10-mediated IFN-γ inhibition in CD4+ T cells,IL-10-mediated IFN-γ inhibition in CD4+ T cells |
R16035 |
T30042 |
T30023 |
themeOf |
"T cells to IL-10 may be associated with defective IL-10-dependent STAT3 activation, but not with IL-10R1 expression","with defective IL-10-dependent STAT3 activation, but not with IL-10R1 expression" |
R16036 |
T30043 |
T30069 |
causeOf |
"by SOCS3 induction in Th2 cells,","IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells," |
R16037 |
T30044 |
T30070 |
causeOf |
"by SOCS3 induction in Th2 cells,","IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells," |
R16038 |
T30058 |
T30072 |
themeOf |
activation of JAK,SOCS1 prevents activation of JAK by directly binding to JAK |
R16039 |
T29944 |
T30036 |
themeOf |
IL-6,IL-6 production [37] |
R16040 |
T30066 |
T30026 |
themeOf |
of IFN-γ production,IL-10 inhibition of IFN-γ production |
R16041 |
T30067 |
T30035 |
themeOf |
"impaired IL-10-dependent STAT3 activation, in association with sustained STAT3 phosphorylation and SOCS1","impaired IL-10-dependent STAT3 activation, in association with sustained STAT3 phosphorylation and SOCS1" |
R16042 |
T29947 |
T30085 |
causeOf |
CD28-costimulated,of CD28-costimulated production of both IFN-γ and IL-2 |
R16043 |
T30068 |
T30054 |
themeOf |
IL-10-mediated STAT3 activation,IL-10-mediated STAT3 activation |
R16044 |
T29947 |
T30086 |
causeOf |
CD28-costimulated,of CD28-costimulated production of both IFN-γ and IL-2 |
R16045 |
T30073 |
T30091 |
themeOf |
IL-4-induced STAT6 signaling,IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells |
R16046 |
T30073 |
T30092 |
themeOf |
IL-4-induced STAT6 signaling,IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells |
R16047 |
T29952 |
T30032 |
themeOf |
SOCS1,"SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7]" |
R16048 |
T30077 |
T30048 |
themeOf |
"IL-10-mediated STAT3 activation,","IL-10-mediated STAT3 activation," |
R16049 |
T30078 |
T30092 |
causeOf |
by SOCS1 induction in Th1 cells,IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells |
R16050 |
T30079 |
T30091 |
causeOf |
by SOCS1 induction in Th1 cells,IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells |
R16051 |
T29952 |
T30033 |
themeOf |
SOCS1,"SOCS1 and SOCS3 are induced by various cytokines, including IL-6 and IL-10, as mediators of negative feedback and crosstalk inhibition [7]" |
R16052 |
T29956 |
T30035 |
causeOf |
impaired IL-10-dependent,"impaired IL-10-dependent STAT3 activation, in association with sustained STAT3 phosphorylation and SOCS1" |
R16053 |
T30081 |
T30069 |
themeOf |
IL-12-induced STAT4 activation,"IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells," |
R16054 |
T30081 |
T30070 |
themeOf |
IL-12-induced STAT4 activation,"IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells," |
R16055 |
T29956 |
T30061 |
themeOf |
impaired IL-10-dependent,impaired IL-10-dependent |
R16056 |
T29959 |
T30114 |
themeOf |
STAT3,STAT3 activation |
R16057 |
T29960 |
T30063 |
themeOf |
impaired IL-10-mediated,impaired IL-10-mediated |
R16058 |
T30093 |
T30049 |
themeOf |
STAT3 activation,IL-10 may persistently stimulate STAT3 activation |
R16059 |
T29960 |
T30076 |
causeOf |
impaired IL-10-mediated,with impaired IL-10-mediated STAT3 activation |
R16060 |
T29961 |
T30062 |
themeOf |
of intracellular IL-10R1,of intracellular IL-10R1 |
R16061 |
T30097 |
T30047 |
themeOf |
"for impaired IL-10 signaling in the ST,","for impaired IL-10 signaling in the ST," |
R16062 |
T29965 |
T30111 |
themeOf |
STAT3 but not STAT1 phosphorylation,Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4+ T cells |
R16063 |
T29965 |
T30112 |
themeOf |
STAT3 but not STAT1 phosphorylation,Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4+ T cells |
R16064 |
T29976 |
T30104 |
themeOf |
STAT3,STAT3 activation has been shown to be involved in synovial fibroblast proliferation and IL-6 production [37] |
R16065 |
T30106 |
T30098 |
themeOf |
This impaired IL-10 signaling,This impaired IL-10 signaling |
R16066 |
T30107 |
T30100 |
themeOf |
gp130-mediated STAT3 activation,gp130-mediated STAT3 activation |
R16067 |
T29979 |
T30099 |
themeOf |
of the CD28 molecule,the tyrosine phosphorylation of the CD28 molecule |
R16068 |
T29985 |
T30037 |
themeOf |
CD28,CD28 costimulation |
R16644 |
T31517 |
T31541 |
themeOf |
STAT3,of IL-6-dependent STAT3 activation |
R16645 |
T31518 |
T31551 |
themeOf |
IFN-γ,"of IFN-γ production," |
R16646 |
T31524 |
T31545 |
themeOf |
of the SOCS3 gene,"the induction of the SOCS3 gene," |
R16647 |
T31524 |
T31546 |
themeOf |
of the SOCS3 gene,"the induction of the SOCS3 gene," |
R16648 |
T31525 |
T31544 |
themeOf |
STAT3,IL-10-mediated STAT3 activation |
R16649 |
T31527 |
T31543 |
causeOf |
IL-6-dependent,of IL-6-dependent STAT3 activation |
R16650 |
T31528 |
T31540 |
themeOf |
STAT3,STAT3 activation |
R16651 |
T31530 |
T31548 |
causeOf |
IL-10,"IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation" |
R16652 |
T31531 |
T31547 |
themeOf |
STAT3,constitutive STAT3 phosphorylation |
R16653 |
T31535 |
T31549 |
causeOf |
IL-10-mediated,IL-10-mediated STAT3 activation |
R16654 |
T31536 |
T31550 |
causeOf |
STAT3,The defective STAT3 signaling |
R16655 |
T31541 |
T31542 |
themeOf |
of IL-6-dependent STAT3 activation,the inhibition of IL-6-dependent STAT3 activation |
R16656 |
T31541 |
T31543 |
themeOf |
of IL-6-dependent STAT3 activation,of IL-6-dependent STAT3 activation |
R16657 |
T31544 |
T31549 |
themeOf |
IL-10-mediated STAT3 activation,IL-10-mediated STAT3 activation |
R16658 |
T31551 |
T31548 |
themeOf |
"of IFN-γ production,","IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation" |
R3098 |
T6199 |
T6347 |
themeOf |
gene,gene transcription |
R3099 |
T6173 |
T6340 |
causeOf |
CD4+ T cells,"In addition, CD4+ T cells could stimulate B-cell production of autoantibodies such as rheumatoid factor" |
R3100 |
T6200 |
T6360 |
themeOf |
of autoantibodies,B-cell production of autoantibodies such as |
R3101 |
T6208 |
T6356 |
themeOf |
IL-10R1,which are constitutively associated with IL-10R1 and type 2 IL-10R |
R3102 |
T6179 |
T6373 |
themeOf |
granulocyte–macrophage colony-stimulating factor [15],granulocyte–macrophage colony-stimulating factor [15] |
R3103 |
T6180 |
T6371 |
themeOf |
cell surface CD69,cell surface CD69 |
R3104 |
T6183 |
T6352 |
themeOf |
CD86,binding to CD80 and CD86 with high avidity [23] |
R3105 |
T6215 |
T6354 |
themeOf |
IL-10,The interaction of IL-10 and IL-10R |
R3106 |
T6189 |
T6351 |
themeOf |
of IL-10R1,Cell surface expression of IL-10R1 |
R3107 |
T6191 |
T6369 |
themeOf |
STAT3,shown that STAT3 activation |
R3108 |
T6216 |
T6374 |
themeOf |
of the latent transcriptional factors signal transducer and activator of transcription (STAT) 3,activation of the latent transcriptional factors signal transducer and activator of transcription (STAT) 3 |
R3109 |
T6217 |
T6365 |
themeOf |
"IL-10, produced by macrophages","IL-10, produced by macrophages" |
R3110 |
T6219 |
T6354 |
themeOf |
IL-10R,The interaction of IL-10 and IL-10R |
R3111 |
T6221 |
T6353 |
themeOf |
STAT3,STAT3 activation induced by IL-6 but not that induced by IL-10 |
R3112 |
T6223 |
T6366 |
themeOf |
SOCS3,the expression of SOCS1 and SOCS3 |
R3113 |
T6226 |
T6357 |
themeOf |
of IFN-γ,investigated the production of IFN-γ |
R3114 |
T6260 |
T6373 |
locationOf |
granulocyte–macrophage,granulocyte–macrophage colony-stimulating factor [15] |
R3115 |
T6229 |
T6350 |
causeOf |
CD28-mediated,"CD28-mediated costimulatory signaling, in RA" |
R3116 |
T6261 |
T6367 |
themeOf |
SOCS1,the expression of SOCS1 and SOCS3 |
R3117 |
T6233 |
T6340 |
themeOf |
B-cell production of autoantibodies such as rheumatoid factor,"In addition, CD4+ T cells could stimulate B-cell production of autoantibodies such as rheumatoid factor" |
R3118 |
T6265 |
T6342 |
causeOf |
IL-10,IL-10 signaling |
R3119 |
T6267 |
T6372 |
causeOf |
IL-6-mediated,responsible for IL-6-mediated prevention of apoptosis |
R3120 |
T6234 |
T6355 |
themeOf |
type 2 IL-10R,which are constitutively associated with IL-10R1 and type 2 IL-10R |
R3121 |
T6235 |
T6358 |
themeOf |
Numerous cytokines,Numerous cytokines are overproduced in the inflamed joint |
R3122 |
T6235 |
T6359 |
themeOf |
Numerous cytokines,Numerous cytokines are overproduced in the inflamed joint |
R3123 |
T6250 |
T6345 |
causeOf |
STAT1,"STAT1 and STAT3 proteins form homodimers or heterodimers, rapidly translocate into the nucleus, and modulate gene transcription" |
R3124 |
T6284 |
T6363 |
themeOf |
STAT3,the induction of STAT1 and STAT3 |
R3125 |
T6284 |
T6364 |
themeOf |
STAT3,the induction of STAT1 and STAT3 |
R3126 |
T6285 |
T6370 |
causeOf |
osteoclast-mediated,osteoclast-mediated bone destruction |
R3127 |
T6292 |
T6352 |
themeOf |
CD80,binding to CD80 and CD86 with high avidity [23] |
R3128 |
T6304 |
T6349 |
themeOf |
component type 1 IL-10R (IL-10R1),the primary ligand-binding component type 1 IL-10R (IL-10R1) |
R3129 |
T6299 |
T6348 |
themeOf |
CD28,CD28 costimulation |
R3130 |
T6306 |
T6346 |
themeOf |
to the IL-10 receptor (IL-10R) complex,IL-10 binds to the IL-10 receptor (IL-10R) complex |
R3131 |
T6309 |
T6361 |
themeOf |
STAT1,the induction of STAT1 and STAT3 |
R3132 |
T6353 |
T6341 |
themeOf |
STAT3 activation induced by IL-6 but not that induced by IL-10,by specifically blocking STAT3 activation induced by IL-6 but not that induced by IL-10 |
R3133 |
T6309 |
T6362 |
themeOf |
STAT1,the induction of STAT1 and STAT3 |
R3134 |
T6311 |
T6344 |
causeOf |
STAT3 proteins,"STAT1 and STAT3 proteins form homodimers or heterodimers, rapidly translocate into the nucleus, and modulate gene transcription" |
R3135 |
T6322 |
T6346 |
themeOf |
IL-10,IL-10 binds to the IL-10 receptor (IL-10R) complex |
R3136 |
T6338 |
T6371 |
locationOf |
cell surface,cell surface CD69 |
R3141 |
T6342 |
T6368 |
themeOf |
IL-10 signaling,IL-10 signaling is impaired in macrophages upon chronic exposure to proinflammatory cytokines such as TNF-α and IL-1 |
R3144 |
T6347 |
T6344 |
themeOf |
gene transcription,"STAT1 and STAT3 proteins form homodimers or heterodimers, rapidly translocate into the nucleus, and modulate gene transcription" |
R3147 |
T6347 |
T6345 |
themeOf |
gene transcription,"STAT1 and STAT3 proteins form homodimers or heterodimers, rapidly translocate into the nucleus, and modulate gene transcription" |
R4655 |
T8969 |
T8978 |
themeOf |
IL-10R1,IL-10R1 expression |
R5460 |
T10522 |
T10535 |
themeOf |
β-actin,β-actin expression |
R612 |
T1871 |
T1907 |
themeOf |
the antigen-specific T-cell cytokine response,the antigen-specific T-cell cytokine response |
R613 |
T1872 |
T1918 |
causeOf |
T cells with IL-6,T cells with IL-6 reduced IL-10-mediated inhibition of interferon gamma production |
R614 |
T1873 |
T1911 |
causeOf |
IL-10-mediated,IL-10-mediated inhibition of interferon gamma production |
R615 |
T1876 |
T1914 |
themeOf |
signal transducer and activator of transcription 3,signal transducer and activator of transcription 3 phosphorylation in normal CD4+ T cells |
R616 |
T1878 |
T1909 |
causeOf |
IL-10,this impaired IL-10 signaling |
R617 |
T1881 |
T1907 |
locationOf |
T-cell,the antigen-specific T-cell cytokine response |
R618 |
T1884 |
T1912 |
themeOf |
anti-IL-6 antibody,neutralizing anti-IL-6 antibody |
R619 |
T1885 |
T1906 |
themeOf |
CD28,CD28 costimulation |
R6194 |
T11831 |
T11890 |
themeOf |
STAT3,"Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits (Cell Signaling Technology," |
R6195 |
T11838 |
T11889 |
themeOf |
STAT,on STAT phosphorylation |
R6196 |
T11845 |
T11892 |
themeOf |
STAT,STAT phosphorylation was compared with the total amount of STAT protein |
R6197 |
T11866 |
T11888 |
causeOf |
of serum IL-6,"To examine the effect of serum IL-6 on STAT phosphorylation," |
R6198 |
T11874 |
T11891 |
themeOf |
STAT1,"Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits (Cell Signaling Technology," |
R6199 |
T11887 |
T11874 |
partOf |
Tyrosine,STAT1 |
R620 |
T1895 |
T1916 |
themeOf |
suppressor of cytokine signaling 1,suppressor of cytokine signaling 1 induction |
R6200 |
T11887 |
T11831 |
partOf |
Tyrosine,STAT3 |
R6201 |
T11887 |
T11890 |
siteOf |
Tyrosine,"Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits (Cell Signaling Technology," |
R6202 |
T11887 |
T11891 |
siteOf |
Tyrosine,"Tyrosine phosphorylation of STAT1 and STAT3 was detected using commercial available kits (Cell Signaling Technology," |
R6203 |
T11889 |
T11888 |
themeOf |
on STAT phosphorylation,"To examine the effect of serum IL-6 on STAT phosphorylation," |
R621 |
T1895 |
T1917 |
themeOf |
suppressor of cytokine signaling 1,suppressor of cytokine signaling 1 induction |
R622 |
T1897 |
T1913 |
themeOf |
signal transducer and activator of transcription 3,sustained signal transducer and activator of transcription 3 activation |
R623 |
T1900 |
T1908 |
themeOf |
of suppressor of cytokine signaling 1,expression of suppressor of cytokine signaling 1 in CD4 |
R624 |
T1902 |
T1910 |
themeOf |
of signal transducer and activator of transcription 3,The phosphorylation of signal transducer and activator of transcription 3 |
R625 |
T1909 |
T1915 |
themeOf |
this impaired IL-10 signaling,this impaired IL-10 signaling |
R7392 |
T14269 |
T14338 |
themeOf |
IFN-γ,on IFN-γ production |
R7393 |
T14280 |
T14343 |
themeOf |
CD28,CD28 costimulation |
R7394 |
T14286 |
T14341 |
themeOf |
IFN-γ,IFN-γ production by CD4+ T cells |
R7395 |
T14296 |
T14349 |
causeOf |
of IL-10,effect of IL-10 on IFN-γ production |
R7396 |
T14297 |
T14339 |
themeOf |
CD28,CD28 costimulation |
R7397 |
T14303 |
T14344 |
themeOf |
IL-2,"In addition, we compared IL-2 production by CD4+ T cells after CD3 and CD28 costimulation" |
R7398 |
T14304 |
T14350 |
themeOf |
IFN-γ,IFN-γ production |
R7399 |
T14307 |
T14345 |
themeOf |
IL-2,IL-2 production |
R7400 |
T14320 |
T14346 |
themeOf |
IFN-γ,IFN-γ production without IL-10 among these three groups |
R7401 |
T14324 |
T14348 |
themeOf |
IFN-γ,IFN-γ production by activated normal CD4+ T cells |
R7402 |
T14326 |
T14336 |
themeOf |
IFN-γ,of IFN-γ production |
R7403 |
T14331 |
T14347 |
causeOf |
by 1 ng/ml IL-10,"IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease," |
R7404 |
T14335 |
T14340 |
causeOf |
IL-10,IL-10 inhibition of IFN-γ production in RA CD4+ T cells |
R7405 |
T14336 |
T14340 |
themeOf |
of IFN-γ production,IL-10 inhibition of IFN-γ production in RA CD4+ T cells |
R7406 |
T14338 |
T14349 |
themeOf |
on IFN-γ production,effect of IL-10 on IFN-γ production |
R7407 |
T14345 |
T14347 |
themeOf |
IL-2 production,"IL-2 production was not affected by 1 ng/ml IL-10 in RA patients (percentage decrease," |
R7408 |
T14349 |
T14337 |
themeOf |
effect of IL-10 on IFN-γ production,effect of IL-10 on IFN-γ production was significantly limited in the active RA group |
R7786 |
T15257 |
T15283 |
themeOf |
of cell surface IL-10R1 on RA CD4+ T cells,of cell surface IL-10R1 on RA CD4+ T cells |
R7787 |
T15259 |
T15283 |
locationOf |
cell surface,of cell surface IL-10R1 on RA CD4+ T cells |
R7788 |
T15268 |
T15284 |
themeOf |
IL-10R1,of IL-10R1 expression |
R7789 |
T15272 |
T15285 |
themeOf |
IL-10,IL-10 inhibition |
R7790 |
T15274 |
T15287 |
themeOf |
receptor,"limited receptor expression," |
R7791 |
T15276 |
T15286 |
themeOf |
IL-10R1,IL-10R1 expression |
R7792 |
T15287 |
T15288 |
themeOf |
"limited receptor expression,","limited receptor expression," |
R8651 |
T16947 |
T17019 |
themeOf |
the major IL-10-activated STAT in CD4+ T cells,the major IL-10-activated STAT in CD4+ T cells |
R8652 |
T16947 |
T17012 |
themeOf |
the major IL-10-activated STAT in CD4+ T cells,the major IL-10-activated STAT in CD4+ T cells |
R8653 |
T16948 |
T17018 |
themeOf |
of the latent transcription factors STAT1,activation of the latent transcription factors STAT1 |
R8654 |
T16949 |
T17010 |
causeOf |
Defective IL-10,Defective IL-10-mediated STAT3 phosphorylation in RA CD4+ T cells |
R8655 |
T16957 |
T17014 |
themeOf |
STAT3,this STAT3 phosphorylation |
R8656 |
T16958 |
T17019 |
locationOf |
CD4+ T cells,the major IL-10-activated STAT in CD4+ T cells |
R8657 |
T16960 |
T17006 |
themeOf |
of IL-10R,The interaction of IL-10R with IL-10 |
R8658 |
T16963 |
T17017 |
themeOf |
negative STAT3,of dominant-negative STAT3 overexpression [30] |
R8659 |
T16963 |
T17016 |
themeOf |
negative STAT3,of dominant-negative STAT3 overexpression [30] |
R8660 |
T16965 |
T17003 |
themeOf |
STAT3,defective IL-10-induced STAT3 phosphorylation |
R8661 |
T16968 |
T17007 |
themeOf |
STAT3,STAT3 phosphorylation in RA CD4+ T cells |
R8662 |
T16971 |
T17008 |
themeOf |
STAT3,"In contrast, STAT3 was phosphorylated in freshly isolated PB CD4+ cells" |
R8663 |
T16978 |
T17012 |
causeOf |
major IL-10-activated,the major IL-10-activated STAT in CD4+ T cells |
R8664 |
T16981 |
T17006 |
themeOf |
with IL-10,The interaction of IL-10R with IL-10 |
R8665 |
T16982 |
T17005 |
themeOf |
STAT3,STAT3 phosphorylation |
R8666 |
T16985 |
T17002 |
themeOf |
STAT3,STAT3 phosphorylation |
R8667 |
T16987 |
T17013 |
themeOf |
IL-10,IL-10 activation for 20 |
R8668 |
T16988 |
T17011 |
themeOf |
STAT3,with sustained STAT3 phosphorylation |
R8669 |
T16989 |
T17015 |
themeOf |
STAT3,IL-10-induced STAT3 activation |
R8670 |
T16990 |
T17020 |
themeOf |
STAT3,STAT3 phosphorylation |
R8671 |
T16991 |
T17004 |
themeOf |
STAT3,STAT3 phosphorylation |
R8672 |
T16996 |
T17009 |
themeOf |
STAT1,"On the other hand, IL-10-induced STAT1 phosphorylation was not detected in either RA CD4+ T cells or normal CD4+ T cells" |
R8673 |
T17007 |
T17010 |
themeOf |
STAT3 phosphorylation in RA CD4+ T cells,Defective IL-10-mediated STAT3 phosphorylation in RA CD4+ T cells |